Musculoskeletal system disorder
MONDO:0002081A disease involving the musculoskeletal system.
Also known as: disease of musculoskeletal system, disease or disorder of musculoskeletal system, disorder of musculoskeletal system, musculoskeletal disease, musculoskeletal system disease, musculoskeletal system disease or disorder, musculoskeletal system disorder, musculoskeletal disorder
12041 clinical trials for this condition and its sub-types, 220 tagged with Musculoskeletal system disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Musculoskeletal system disorder
-
Skeletal system disorder 4 trials · 9,737 incl. sub-types
48 sub-types
- Bone disorder 53 trials · 6,305 incl. sub-types Sub-types →
- Arthropathy 139 trials · 3,208 incl. sub-types Sub-types →
- Bone marrow disorder 18 trials · 1,763 incl. sub-types Sub-types →
- Vertebral column disorder 82 trials · 1,243 incl. sub-types Sub-types →
- Periodontal disorder 303 trials · 982 incl. sub-types Sub-types →
- Tooth disorder 38 trials · 892 incl. sub-types Sub-types →
- Flatfoot 60 trials
- Patellar tendinitis 22 trials
- Marfan syndrome 21 trials Sub-types →
- Fibrodysplasia ossificans progressiva 10 trials
- Polydactyly 2 trials · 9 incl. sub-types Sub-types →
- Syndactyly 3 trials · 9 incl. sub-types Sub-types →
- Skeletal ligament disorder 0 trials · 7 incl. sub-types Sub-types →
- Chondroma 4 trials Sub-types →
- Coffin-Siris syndrome 1 trial Sub-types →
- Cartilage-hair hypoplasia 1 trial Sub-types →
- Cherubism 1 trial Sub-types →
- Ochronosis disorder 1 trial Sub-types →
- Ossification of the posterior longitudinal ligament of the spine 1 trial
- Primary basilar invagination 1 trial
- Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome 1 trial
- Symphalangism 0 trials · 1 incl. sub-types Sub-types →
- Al-Gazali syndrome 0 trials
- Brachymorphism-onychodysplasia-dysphalangism syndrome 0 trials
- Buschke-Ollendorff syndrome 0 trials
- Rienhoff syndrome 0 trials
- Teebi-Shaltout syndrome 0 trials
- Anterior cranial fossa meningioma 0 trials Sub-types →
- Brachydactyly 0 trials Sub-types →
- Brachydactyly-syndactyly syndrome 0 trials
- Brachydactyly-syndactyly-oligodactyly syndrome 0 trials
- Cartilage cancer 0 trials
- Cartilage development disorder 0 trials
- Cranial nodular fasciitis 0 trials
- Endocrine-cerebro-osteodysplasia syndrome 0 trials
- Laryngeal cartilage cancer 0 trials
- Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria 0 trials
- Metaphyseal undermodeling, spondylar dysplasia, and overgrowth 0 trials
- Microcephaly-brachydactyly-kyphoscoliosis syndrome 0 trials
- Middle cranial fossa meningioma 0 trials Sub-types →
- Multiple congenital anomalies-hypotonia-seizures syndrome 3 0 trials
- Necrosis of ear ossicle 0 trials
- Posterior cranial fossa meningioma 0 trials Sub-types →
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis 0 trials
- Skeletal tuberculosis 0 trials Sub-types →
- Sternal neoplasm 0 trials Sub-types →
- Temtamy preaxial brachydactyly syndrome 0 trials
-
Muscle tissue disorder 58 trials · 2,427 incl. sub-types
13 sub-types
- Skeletal muscle disorder 11 trials · 1,366 incl. sub-types Sub-types →
- Cardiomyopathy 155 trials · 823 incl. sub-types Sub-types →
- Myomatous neoplasm 1 trial · 188 incl. sub-types Sub-types →
- Myalgic encephalomeyelitis/chronic fatigue syndrome 75 trials
- Conduction system disorder 8 trials · 46 incl. sub-types Sub-types →
- Myostatin-related muscle hypertrophy 10 trials
- Atrophic muscular disease 7 trials
- Distal arthrogryposis 0 trials · 3 incl. sub-types Sub-types →
- Kocher-debre-Semelaigne syndrome 0 trials
- Caveolinopathy 0 trials Sub-types →
- Septal myocardial infarction 0 trials
- Striated muscle rhabdoid tumor 0 trials
- Tonsillar pillar cancer 0 trials
-
Musculoskeletal system cancer 2 trials · 1,970 incl. sub-types
11 sub-types
- Bone cancer 79 trials · 1,923 incl. sub-types Sub-types →
- Muscle cancer 0 trials · 72 incl. sub-types Sub-types →
- Gingival cancer 1 trial · 2 incl. sub-types Sub-types →
- Synovium cancer 1 trial · 2 incl. sub-types Sub-types →
- Ameloblastic carcinoma 0 trials
- Broad ligament malignant neoplasm 0 trials Sub-types →
- Cartilage cancer 0 trials
- Laryngeal cartilage cancer 0 trials
- Round ligament malignant neoplasm 0 trials
- Tonsillar pillar cancer 0 trials
- Uterine ligament cancer 0 trials Sub-types →
-
Autoimmune disorder of musculoskeletal system 0 trials · 797 incl. sub-types
3 sub-types
- Rheumatoid arthritis 578 trials · 797 incl. sub-types Sub-types →
- Autoimmune cardiomyopathy 0 trials Sub-types →
- Neonatal dermatomyositis 0 trials
-
Musculoskeletal system benign neoplasm 0 trials · 224 incl. sub-types
8 sub-types
- Benign muscle neoplasm 4 trials · 118 incl. sub-types Sub-types →
- Benign connective and soft tissue neoplasm 0 trials · 101 incl. sub-types Sub-types →
- Chondroma 4 trials Sub-types →
- Ameloblastoma 2 trials Sub-types →
- Benign neoplasm of gum 0 trials Sub-types →
- Benign neoplasm of sternum 0 trials
- Benign skeletal muscle neoplasm 0 trials
- Benign uterine ligament neoplasm 0 trials
-
Disease of the tendon 126 trials · 192 incl. sub-types
3 sub-types
- Tendinitis 24 trials · 77 incl. sub-types Sub-types →
- Tendon sheath disorder 0 trials · 30 incl. sub-types Sub-types →
- Tendinosis 17 trials
-
Synovium disorder 0 trials · 149 incl. sub-types
4 sub-types
- Synovial bursa disorder 0 trials · 119 incl. sub-types Sub-types →
- Synovium neoplasm 0 trials · 17 incl. sub-types Sub-types →
- Synovitis 15 trials Sub-types →
- Synovial plica syndrome 1 trial
-
Fasciitis 7 trials · 97 incl. sub-types
6 sub-types
- Plantar fasciitis 85 trials
- Necrotizing fasciitis 7 trials
- Eosinophilic fasciitis 1 trial
- Ischemic fasciitis 0 trials
- Nodular fasciitis 0 trials Sub-types →
- Proliferative fasciitis 0 trials
-
Ligament disorder 8 trials · 15 incl. sub-types
4 sub-types
- Skeletal ligament disorder 0 trials · 7 incl. sub-types Sub-types →
- Disorder of uterine broad ligament 0 trials Sub-types →
- Round ligament malignant neoplasm 0 trials
- Uterine ligament neoplasm 0 trials Sub-types →
-
Klippel-Feil syndrome 14 trials
6 sub-types
- Calabro syndrome 0 trials
- Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome 0 trials
- Klippel-Feil syndrome 1, autosomal dominant 0 trials
- Klippel-Feil syndrome 2, autosomal recessive 0 trials
- Klippel-Feil syndrome 3, autosomal dominant 0 trials
- Wildervanck syndrome 0 trials
-
CINCA syndrome 4 trials
-
Enthesopathy 2 trials · 4 incl. sub-types
5 sub-types
- Enthesitis 2 trials
- Fibular collateral ligament bursitis 0 trials
- Olecranon bursitis 0 trials
- Pes anserinus tendinitis or bursitis 0 trials
- Tibial collateral ligament bursitis 0 trials
-
Ramon syndrome 0 trials
-
Short stature, Dauber-Argente type 0 trials
-
Upington disease 0 trials
-
Auriculoosteodysplasia 0 trials
-
Short stature, Brussels type 0 trials
-
Synovial chondromatosis 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 4215 trials in this tab.
-
Engineered t cells target FLT3 in Hard-to-Treat leukemia
Cure Recruiting nowResearchers are testing a new cell therapy called anti-FLT3 CAR-T (HG-CT-1) in adults and children with acute myeloid leukemia (AML) that has come back or stopped responding to standard treatment. The study is a Phase 1 dose-escalation trial, meaning its first goal is to find out…
Phase 1 • Sponsor: Hemogenyx Pharmaceuticals LLC • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Can adding venetoclax make donor stem cell transplants safer for High-Risk blood cancers?
Cure Recruiting nowResearchers test whether adding venetoclax to a standard conditioning regimen called FLAMSA-treosulfan is safe for people with high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or secondary acute myeloid leukemia who are receiving a donor blood stem cell trans…
Phase 1/2 • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Half-Matched stem cells tested as a cure for severe aplastic anemia
Cure Recruiting nowResearchers are testing a stem cell transplant from a half-matched family member in children and young adults with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. Participants receive chemotherapy and radiation to prepare their body, the…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a Four-Drug prep make curative transplant safer for older AML patients?
Cure Recruiting nowOlder adults with acute myeloid leukemia (AML) often fare poorly with chemotherapy alone, and a stem cell transplant can offer better long-term survival but carries a high risk of transplant-related death. Researchers are comparing two drug combinations given before a haploidenti…
Sponsor: Peking University People's Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Half-Matched stem cells tested as cure for myelofibrosis
Cure Recruiting nowMyelofibrosis is a bone marrow disease that can lead to leukemia. A stem cell transplant from a matched donor can cure it, but many patients cannot find a match. This trial tests a new transplant protocol using half-matched family donors, with a special drug regimen before transp…
Sponsor: Peking University People's Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
New drug ABBV-519 enters first human tests for lupus and arthritis
Disease control Recruiting nowThis early-stage study tests a single dose of ABBV-519 in 30 adults with moderate lupus or rheumatoid arthritis. Researchers will check how the drug moves through the body, how it affects immune cells, and whether it is safe. Participants will be followed for about a year to moni…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for rare blood cancers: pacritinib trial opens for teens and adults
Disease control Recruiting nowThis study tests an oral drug called pacritinib in people aged 12 and older with myelodysplastic syndromes (MDS) or related blood cancers (MDS/MPN). The goal is to find the best dose and see if it can shrink or control the disease. Participants take capsules twice daily for up to…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Second-Chance stem cell therapy for blood cancer patients
Disease control Expanded accessThis program gives patients with certain blood cancers access to Orca-T, a donor stem cell therapy, when the commercial version cannot be used. It is for people who have no other treatment options. The program monitors safety but does not test if the therapy works.
Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Gene therapy trial hopes to tackle muscle disease
Disease control Recruiting nowThis study tests a gene therapy called SAR446268 for people aged 10 to 55 with myotonic dystrophy type 1. The therapy is given once through an IV and aims to reduce harmful DMPK RNA and improve muscle function. The trial has two parts: first, finding the safest dose in a small gr…
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for kids with sanfilippo syndrome b?
Disease control Recruiting nowThis early-stage trial tests a new drug called JR-446 in 12 children under 6 with MPS IIIB, a rare genetic disorder that damages the brain and body. The main goal is to see if the drug is safe and tolerable. Researchers will also measure changes in certain substances in the body …
Phase 1/2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a weekly brain infusion slow sanfilippo syndrome?
Disease control Expanded accessThis early-access program tests whether a weekly infusion of tralesinidase alfa directly into the brain's fluid spaces is safe and tolerable for children with Sanfilippo syndrome type B, a rare genetic disorder that causes severe neurological decline. The study enrolls about 10 c…
Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for young AML patients: targeted drug combo tested in phase 2 trial
Disease control Recruiting nowThis study tests two different drug combinations for younger adults with a specific type of acute myeloid leukemia (CBF-AML). One group gets standard chemotherapy plus a targeted antibody, while the other gets the same chemotherapy plus a newer targeted pill. The goal is to see w…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Magnifying the fight against gum disease: loupe vs microscope
Disease control Recruiting nowResearchers compare two magnification tools, dental loupes and a dental operating microscope, during non-surgical deep cleaning for stage 3 periodontitis. Thirty adults with the disease receive scaling and root planing on different areas of the mouth, one area cleaned with loupes…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Poop pills could tame stubborn arthritis
Disease control Recruiting nowThis study tests whether freeze-dried fecal bacteria, given as oral capsules, can improve symptoms in 40 adults with active rheumatoid arthritis that hasn't responded to standard drugs. Participants will receive either the fecal transplant or a placebo for 24 weeks. The main goal…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for rare bone disease: first human trial of KK8123 begins
Disease control Recruiting nowThis study tests a new drug called KK8123 for adults with X-linked hypophosphatemia (XLH), a rare genetic condition that causes low phosphate levels and bone problems. The trial has two parts: first, finding the right dose, then checking safety and how well it works over time. Ab…
Phase 1/2 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hip replacement device put to the test in 288-Patient trial
Disease control Recruiting nowThis study is testing a new hip replacement system called the HIT Reverse Hip Replacement System. It is for people aged 50 to 75 who need a total hip replacement due to arthritis, joint damage, or other conditions. The goal is to see if the new system is as safe and effective as …
Sponsor: Hip Innovation Technology • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New pill hopes to tame rare childhood brain diseases
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called nizubaglustat (AZ-3102) in people aged 4 and older with Niemann-Pick type C disease, GM1 gangliosidosis, or GM2 gangliosidosis. The study lasts 18 months and compares the drug to a placebo to see if it is safe and can slow disease prog…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Could a faster pacemaker setting boost heart and brain health?
Disease control Recruiting nowThis study looks at whether setting a pacemaker to a personalized rate of 75 beats per minute, instead of the usual 50-60, can improve heart function and blood flow to the brain in people with high blood pressure and a slow heart rate. About 70 patients aged 65 and older will be …
Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for AML patients: Triple-Drug combo targets Tough-to-Treat leukemia
Disease control Recruiting nowThis study tests whether adding pivekimab sunirine to the standard drugs venetoclax and azacitidine helps adults with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. About 660 participants will be randomly assigned to receive ei…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Experimental gene therapy offers hope for fatal nerve disease
Disease control Recruiting nowThis study tests a gene therapy for GM1 gangliosidosis, a fatal disorder that destroys nerve cells. The therapy uses a harmless virus to deliver a working gene, helping the body produce a missing enzyme. Up to 54 children with Type I (ages 6-12 months) or Type II (ages 1-12 years…
Phase 1/2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Fish oil capsules could ease rare muscle disease
Disease control Recruiting nowThis study tests whether omega-3 fatty acid supplements from fish oil, combined with a healthy diet, can reduce disease activity in adults with dermatomyositis, a rare autoimmune disease causing muscle weakness and skin rashes. About 300 participants will take either fish oil cap…
Phase 2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Weekly pill cocktail aims to tame resistant blood cancers
Disease control Recruiting nowThis phase 2 trial tests whether a once-weekly oral combination of decitabine-cedazuridine and venetoclax is safer and as effective as standard therapy for people with relapsed or refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, or high-risk myeloproliferati…
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for tough arthritis cases: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called Afimkibart (RO7790121) in 160 people with moderate to severe rheumatoid arthritis who did not get better with or could not tolerate standard treatments like TNF or JAK inhibitors. Participants will receive either the drug or a placebo …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Viruses that kill bacteria: a new weapon against superbugs?
Disease control Recruiting nowThis study tests personalized phage therapy in people with serious infections that have not responded to antibiotics or surgery. Researchers will collect data before, during, and after treatment to see how safe and effective phage therapy is, and how it affects different body sit…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New combo aims to wipe out stubborn leukemia traces
Disease control Recruiting nowThis study tests whether two drugs, venetoclax and revumenib, can control minimal residual disease (MRD) in people with acute myeloid leukemia (AML). MRD means small numbers of cancer cells remain after initial treatment, raising the risk of relapse. The trial enrolls about 8 par…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to tame back inflammation in axial spondyloarthritis
Disease control Recruiting nowThis study tests an experimental oral drug called GRWD0715 for axial spondyloarthritis, a chronic inflammatory condition affecting the spine and pelvis. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduces inflammation and im…
Phase 1/2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill combo aims to tackle tough leukemia
Disease control Recruiting nowThis early-stage trial tests two oral drugs, ziftomenib and quizartinib, together in adults with relapsed or hard-to-treat acute myeloid leukemia (AML) that has certain genetic markers. The goal is to find a safe and effective all-pill treatment for common AML subtypes. About 44 …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Two-Drug combo targets leukemia that outsmarted its first treatment
Disease control Recruiting nowResearchers are testing whether adding an experimental drug called RVU120 to venetoclax can help adults with acute myeloid leukemia (AML) that has come back or stopped responding to earlier venetoclax-based treatment. The trial enrolls about 98 adults who have already failed a hy…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study tests if asthma drug can stop symptoms Long-Term
Disease control Recruiting nowThis study follows 335 adults with severe eosinophilic asthma who are taking benralizumab. Researchers want to see if the drug helps patients achieve partial or complete clinical remission—meaning fewer symptoms, no need for steroid pills, and better lung function—over 12 to 24 m…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThis study tests whether an investigational drug called PLG0206 can prevent infections from coming back after knee replacement surgery. About 240 adults who need a special cleaning surgery (DAIR) for an infected knee joint will receive either PLG0206 or a placebo during the proce…
Phase 2/3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo shows promise in AML fight
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy can better treat acute myeloid leukemia (AML) that is newly diagnosed or has come back. About 116 adults with AML or high-risk MDS will receive the combination. The goal is to see if the combo improves r…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cell therapy trial aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-phase trial is testing an injection called GT719 in 10 adults with moderate to severe autoimmune diseases that haven't responded to other treatments. The main goal is to check safety and find the right dose. Researchers will also look for signs that the therapy might h…
Early phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Injectable hydrogel could ease back pain without surgery
Disease control Recruiting nowThis study tests a hydrogel implant injected into damaged spinal discs to treat degenerative disc disease. About 225 adults with chronic low back pain will receive either the implant or standard care like physical therapy. The goal is to see if the implant safely improves pain an…
Sponsor: ReGelTec, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims for deeper remission in older leukemia patients
Disease control Recruiting nowThis phase II trial tests whether adding gilteritinib to the usual two-drug therapy (azacitidine and venetoclax) can help older or frail adults with a specific type of acute myeloid leukemia (FLT3-mutated) achieve deeper remission. About 147 participants will be randomly assigned…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Immune-Targeting drug surovatamig enters first human tests for arthritis and lupus
Disease control Recruiting nowThis Phase 1 trial tests surovatamig, a bispecific T-cell engager, in 48 adults with rheumatoid arthritis or systemic lupus erythematosus. The study gives the drug as injections in increasing doses to check safety, side effects, and how the body processes it. It is too early to k…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a targeted drug boost chemo success in leukemia?
Disease control Recruiting nowThis phase II trial is testing whether adding the drug venetoclax to standard chemotherapy can improve remission rates in younger patients with intermediate-risk acute myeloid leukemia (AML). About 153 participants will receive either standard chemo or a combination with venetocl…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill could transform leukemia treatment, phase 3 trial begins
Disease control Recruiting nowThis study tests a new oral drug, QTX-2101, combined with standard ATRA therapy for adults newly diagnosed with a low-risk form of acute promyelocytic leukemia (APL). The goal is to see if the oral capsule works as well as the current intravenous treatment. About 150 participants…
Phase 3 • Sponsor: Quetzal Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Boosting transplants with donor immune cells to fight blood cancer relapse
Disease control Recruiting nowThis study tests whether giving donor white blood cells (lymphocytes) soon after a stem cell transplant can lower the chance of cancer returning in people with high-risk blood cancers like leukemia or lymphoma. Participants receive chemotherapy, a stem cell transplant, and then a…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cocktail of 5 drugs targets tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for leukemia patients: olverembatinib trial launches
Disease control Recruiting nowThis phase 2 trial tests whether the drug olverembatinib can safely control chronic myeloid leukemia (CML) in people who are newly diagnosed. About 50 adults will take the drug by mouth. Researchers will track side effects and how well the drug works. The study is currently recru…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill for duchenne MD enters Mid-Stage trial in young boys
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …
Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for kids with rare blood disorders: benralizumab trial launches
Disease control Recruiting nowThis Phase 3 trial tests the drug benralizumab (Fasenra) in children aged 6 to 17 with two rare eosinophilic diseases: EGPA and HES. The study aims to see if the drug is safe, how it works in the body, and whether it can help control the disease. Fourteen children will receive in…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: first human trial of PRT12396 begins
Disease control Recruiting nowThis early-stage study tests a new drug, PRT12396, in about 100 people with polycythemia vera or myelofibrosis—rare blood cancers. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug controls the disease, but this …
Phase 1 • Sponsor: Prelude Therapeutics Incorporated • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost remission in IDH2-Mutated AML
Disease control Recruiting nowThis phase II trial tests whether adding enasidenib to standard ASTX727 and venetoclax improves remission rates in older adults (or younger unfit patients) with newly diagnosed IDH2-mutated acute myeloid leukemia (AML). About 93 participants will be randomly assigned to receive e…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to tackle rare nasal cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can shrink advanced squamous cell cancers of the nasal cavity and sinuses better than chemotherapy alone. About 35 adults with newly diagnosed, untreated stage II to IVb disease …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a Rose-Scented oil replace standard fillings in Kids' cavities?
Disease control Recruiting nowThis study looks at whether an essential oil from Pelargonium graveolens (a type of geranium) can be used to treat deep cavities in children's baby teeth. The goal is to see if it works as well as current materials to relieve pain and prevent infection. Thirty children will recei…
Sponsor: Tanta University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for Tough-to-Treat leukemia: multiple drug cocktails tested
Disease control Recruiting nowThis phase II trial tests several experimental drug combinations against the standard treatment for high-risk acute myeloid leukemia (AML) in patients aged 59 or younger. The goal is to see if newer regimens, including venetoclax and liposome formulations, can better shrink cance…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a cementless hip stem hold up in asian patients?
Disease control Recruiting nowResearchers at a Korean hospital are following 210 adults who receive a cementless total hip replacement using the collarless Actis femoral stem. The study focuses on Asian patients, who tend to be younger at surgery and more often need the operation because of lost blood supply …
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo pill aims to shrink spleens and ease symptoms in bone marrow cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding pelabresib to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a type of bone marrow cancer. About 460 adults who have not taken JAK inhibitors before will receive either the combination or a …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Gene-Silencing drug tame a rare heart disease?
Disease control Recruiting nowThis trial tests an investigational medicine called ATR 1072 in adults with PRKAG2 syndrome, a genetic condition that causes abnormal heart muscle thickening and rhythm problems. The drug is designed to reduce the activity of the faulty PRKAG2 gene. Researchers are evaluating its…
Phase 1/2 • Sponsor: Atrium Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug afimkibart tested for Long-Term arthritis control
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of a drug called afimkibart in people with moderate to severe rheumatoid arthritis. Participants have already taken afimkibart in a previous study and will continue taking it. The goal is to see if the drug remains safe…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could detoxing metals boost chemo for leukemia?
Disease control Recruiting nowThis early-stage trial is testing whether two drugs that lower metal levels in the body can help people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) respond better to chemotherapy. The study will enroll 58 adults and aims to find the safest dose and check f…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could your own bone marrow cells save your hip from collapse?
Disease control Recruiting nowThis study tests whether adding a patient's own concentrated bone marrow cells to a standard hip surgery (core decompression) can prevent the hip ball from collapsing and delay or avoid the need for a hip replacement. It includes 192 adults with early-stage osteonecrosis (before …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug ease the joint pain of psoriatic arthritis?
Disease control Recruiting nowThis trial tests an experimental drug called DDY391 in about 220 adults with moderate to severe psoriatic arthritis, a condition that causes joint pain, swelling, and skin patches. Researchers want to see whether DDY391 can reduce joint symptoms better than a placebo and at what …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered immune cells take on muscle disease
Disease control Recruiting nowThis study tests a one-time treatment called CABA-201, made from a patient's own immune cells, for people with active inflammatory muscle diseases like dermatomyositis. The therapy aims to reset the immune system by targeting and removing certain immune cells. Researchers will ch…
Phase 2/3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to boost transplant success in rare blood cancer
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) plus a targeted therapy (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPN) get to transplant and have better outcomes. About 25 adult…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a tailored diet boost brain and body health in denture-wearers?
Disease control Recruiting nowThis study tests a 6-month nutritional program for adults aged 60–80 who wear complete dentures. Participants receive personalized dietary advice, meal plans, cooking workshops, and a mobile app. The goal is to see if the program improves diet quality, chewing ability, muscle str…
Sponsor: Universidad de La Frontera • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered t cells target hidden leukemia cells in new trial
Disease control Recruiting nowThis phase I trial tests a new treatment for adults with acute myeloid leukemia (AML) who have minimal residual disease (MRD) — small amounts of cancer cells that remain after standard therapy. The treatment uses the patient's own T cells, genetically modified to recognize a prot…
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Recruiting nowThis study tests a daily injection called elamipretide in 48 people with genetically confirmed Barth syndrome, a rare condition that causes muscle weakness and heart problems. Participants will receive either the drug or a placebo for 72 weeks. The main goal is to see if the drug…
Phase 4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis without biologics
Disease control Recruiting nowThis Phase 3 study tests whether the oral drug zasocitinib (TAK-279) can improve symptoms of active psoriatic arthritis in people who have never used biologic treatments. About 1,088 adults will receive either zasocitinib, an active comparator, or a placebo for up to 60 weeks. Th…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody tested to tame childhood arthritis and cut steroid use
Disease control Recruiting nowResearchers are testing an experimental drug called GenaKumab in children and teens with active systemic juvenile idiopathic arthritis, a condition that causes joint inflammation and recurring fevers. The trial enrolls about 290 participants aged 2 to under 18 who have had sympto…
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
3D printed dentures face off against traditional milled ones in new trial
Disease control Recruiting nowThis study compares two types of full dentures: 3D printed ones and milled ones. Researchers want to see which lasts longer and causes fewer problems over five years. Sixty-eight adults who need complete dentures will take part, and the main focus is how many dentures are still w…
Sponsor: Dentsply Sirona Implants and Consumables • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising new treatment for rare Muscle-Weakening disease enters human trials
Disease control Recruiting nowThis study tests a drug called ublituximab for people with a rare autoimmune disease that causes severe muscle weakness. The goal is to see if adding this drug to standard treatment improves muscle strength and function more than standard treatment alone. About 30 adults with ear…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new anesthetic give surgeons a clearer view during sinus surgery?
Disease control Recruiting nowThis trial tests whether fospropofol disodium, a newer form of propofol, can improve the surgical field quality during endoscopic sinus surgery compared to standard propofol anesthesia. The study includes adults aged 18-65 with chronic rhinosinusitis who are scheduled for sinus s…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Which drug first? trial tests sequence of carboplatin and olaparib in aggressive prostate cancer
Disease control Recruiting nowResearchers are comparing two sequences of treatment for metastatic castration-resistant prostate cancer that carries certain DNA repair gene mutations. Participants receive either carboplatin first and olaparib second, or olaparib first and carboplatin second, switching after th…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a new drug combo beat standard chemo for kids with AML?
Disease control Recruiting nowThis large phase 3 trial is testing whether a new formulation of two chemotherapy drugs (CPX-351) and a targeted drug called gilteritinib can improve outcomes for children and young adults with newly diagnosed acute myeloid leukemia (AML). The study compares these new approaches …
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two drugs aim to restore energy factories in rare muscle disease
Disease control Recruiting nowResearchers are testing a combination of two drugs, doxecitine and doxribtimine, in adults with thymidine kinase 2 (TK2) deficiency, a rare genetic condition that causes muscle weakness and breathing problems. The study will enroll about 15 adults with moderate to severe disease.…
Phase 2 • Sponsor: Cristina Domínguez González • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye drug aims to offer cheaper option for blinding disease
Disease control Recruiting nowThis phase 3 trial tests whether a new drug called ABP 938 works as well as the approved treatment Eylea HD for wet age-related macular degeneration, a leading cause of vision loss. About 304 people aged 50 and older with untreated wet AMD will receive injections of either drug i…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo attack on stubborn leukemia: chemo then transplant
Disease control Recruiting nowThis early-phase trial tests a two-step approach for people with acute myeloid leukemia or related blood cancers that have returned or not responded to treatment. First, patients receive intensive chemotherapy (CLAG-M or FLAG-Ida) followed immediately by a reduced-intensity stem …
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for kids with leukemia: new drug combo aims to boost remission
Disease control Recruiting nowThis phase 2 trial tests whether adding the targeted drug venetoclax to standard chemotherapy is safe and effective for children and young adults (up to age 22) with newly diagnosed acute myeloid leukemia (AML). The study aims to see if this combination can reduce the amount of c…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New triple therapy aims to boost survival in frail AML patients
Disease control Recruiting nowThis phase 3 trial will test whether adding the drug quizartinib to the standard two-drug combination (venetoclax and azacitidine) helps adults with newly diagnosed acute myeloid leukemia (AML) live longer. The study includes 376 people aged 18 and older who cannot receive intens…
Phase 3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for myelofibrosis patients: experimental pill targets resistant disease
Disease control Recruiting nowThis early-stage study tests an experimental oral drug, AJ1-11095, in about 76 adults with myelofibrosis (a type of bone marrow cancer) whose disease has stopped responding to standard JAK2 inhibitor therapy. The main goals are to check the drug's safety, find the best dose, and …
Phase 1 • Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Stem cell gel could offer new hope for knee arthritis sufferers
Disease control Recruiting nowThis Phase 3 trial tests whether a gel made from donated umbilical cord stem cells (CARTISTEM) can reduce pain and improve knee function better than a simple surgical cleanup (debridement) in people with knee cartilage damage and osteoarthritis. About 300 adults aged 18-75 with m…
Phase 3 • Sponsor: Medipost, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could everyday heart drugs shield cancer patients from Radiation's cardiac toll?
Disease control Recruiting nowThis study tests whether two common heart medications—atorvastatin (a statin) and lisinopril (an ACE inhibitor)—can prevent or reduce heart damage caused by radiation therapy for chest cancers like breast, lung, and esophageal cancer. About 60 adults receiving chest radiation wil…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New spinal device aims to improve back surgery outcomes
Disease control Recruiting nowThis study tests a new device called CORUS-LX for spinal fusion surgery in people with degenerative disc disease in the lower back. About 250 adults will either get the new device or standard surgery. The goal is to see if the device helps bones fuse better and reduces the need f…
Sponsor: Providence Medical Technology, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo aims to shrink spleen and boost transplant success in myelofibrosis
Disease control Recruiting nowThis study tests whether giving high-dose ruxolitinib and busulfan before a stem cell transplant can reduce spleen size and help the transplant work better in people with myelofibrosis. About 30 adults aged 18 to 75 with an enlarged spleen and a matched donor will take part. The …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a heart drug tame rheumatoid arthritis?
Disease control Recruiting nowThis trial tests whether nicorandil, a drug currently used for heart conditions, can reduce disease activity and symptoms in people with rheumatoid arthritis. About 70 adults with moderate-to-severe RA will take either nicorandil or a placebo twice daily for three months, while c…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for tough leukemias: experimental pill targets genetic weakness
Disease control Recruiting nowThis study tests an oral drug called revumenib in people with certain types of leukemia that have relapsed or not responded to standard therapy. The trial has two parts: first, finding the best dose, then testing that dose in four groups based on leukemia type. About 447 particip…
Phase 1/2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for AML patients: quizartinib maintenance trial launches
Disease control Recruiting nowThis study tests two different doses of the drug quizartinib as a maintenance therapy for adults with a specific type of acute myeloid leukemia (FLT3-ITD positive) who are in their first complete remission after initial treatment and have not had a stem cell transplant. The goal …
Phase 2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase 2 trial tests a combination of three chemotherapy drugs (treosulfan, fludarabine, thiotepa) plus an immune-suppressing antibody before a donor stem cell transplant in up to 40 people under 50 with non-cancerous blood disorders. The goal is to see if this milder conditi…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for leukemia patients who failed standard treatments
Disease control Recruiting nowThis study tests a drug called ponatinib in 50 adults with chronic myeloid leukemia (CML) whose cancer did not respond to or they could not tolerate other targeted therapies. The goal is to see if ponatinib can control the disease by blocking a protein that helps cancer cells gro…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Weekly shot aims to melt away pounds in obesity fight
Disease control Recruiting nowResearchers are testing a new once-weekly injection called NNC0487-0111 in about 400 Japanese adults with overweight or obesity. Half the participants receive the drug and half receive a placebo, assigned by chance. The main goal is to measure how much body weight changes over th…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Engineered t cells take aim at stubborn leukemias in early trial
Disease control Recruiting nowThis early-phase study tests a new type of immune therapy for people with certain blood cancers (leukemias) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells c…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to halt lung damage in autoimmune patients
Disease control Recruiting nowThis study tests whether the drug nerandomilast can slow lung scarring in people with autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults whose lung function hasn't improved with standard treatment will take either nerandomilast or a placebo twice daily…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Promising new combo tackles tough leukemia
Disease control Recruiting nowThis study tests a new mix of drugs for people newly diagnosed with a specific type of acute myeloid leukemia (AML). The treatment combines a targeted drug (venetoclax) with two chemotherapy drugs, then switches to another chemo drug plus venetoclax. The goal is to see if this ap…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to cut deaths and heart crises in rare amyloidosis
Disease control Recruiting nowThis Phase 3 study tests a drug called nucresiran in 1250 people with ATTR amyloidosis, a rare disease where abnormal proteins damage the heart. Participants receive either nucresiran or a placebo every 6 months. The goal is to see if the drug reduces deaths and heart-related hos…
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Promising new combo therapy for infant leukemia shows potential
Disease control Recruiting nowThis study tests whether adding two targeted drugs, blinatumomab and venetoclax, to standard chemotherapy can improve outcomes for infants with a type of leukemia called acute lymphoblastic leukemia (ALL). About 153 infants will participate. The goal is to see if these combinatio…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug hopes to ease rare muscle diseases
Disease control Recruiting nowThis Phase 3 trial tests a drug called dazukibart in people with active dermatomyositis or polymyositis, rare diseases that cause muscle weakness and inflammation. About 318 adults will receive either the drug or a placebo by IV every 4 weeks for 48 weeks. The study aims to see i…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Braces vs. clear aligners: which is gentler on your gums?
Disease control Recruiting nowThis trial asks whether clear aligners are kinder to gum health than traditional braces during the first three months of orthodontic treatment. Thirty healthy adults with mild crowding will receive either braces or clear aligners, after all participants get a standard teeth clean…
Sponsor: Ravan Mammadov • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New transplant recipe targets tough leukemia
Disease control Recruiting nowThis study is for people with a high-risk type of leukemia called CMML. It tests a stronger chemotherapy combination (including thiotepa) given before a stem cell transplant from a donor. The goal is to see if this approach helps patients live longer without the cancer coming bac…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
A plant compound may help young teeth heal themselves
Disease control Recruiting nowThis trial tests whether a plant-derived compound called asiaticoside, placed inside the tooth, can improve the revascularization process in immature permanent teeth with dead nerves. Researchers will compare asiaticoside to the standard calcium hydroxide medication. The goal is …
Sponsor: Mansoura University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for cancer patients with autoimmune conditions: immune checkpoint inhibitor trial expands access
Disease control Recruiting nowThis study is for people who have both an autoimmune disease (like rheumatoid arthritis, lupus, or multiple sclerosis) and an advanced cancer that has spread or cannot be removed by surgery. It tests the safety and effectiveness of the immunotherapy drug nivolumab, given alone or…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for rare blood cancer: experimental drug targets mast cells
Disease control Recruiting nowThis study tests an experimental drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by blocking a key protein that drives abnormal mast cell growth. About 140 adults with aggre…
Phase 2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Hope for duchenne: new drug targets rare gene mutation in phase 3 trial
Disease control Recruiting nowThis study tests an experimental drug called AOC 1044 for boys with Duchenne muscular dystrophy (DMD) who have a specific genetic change (exon 44 skipping). About 70 boys aged 7 to 16 who can still walk will receive either the drug or a placebo. The main goal is to see if the dru…
Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immune cells harvested from tumors could fight advanced cancers
Disease control Recruiting nowThis early-stage trial tests a personalized cell therapy called lifileucel for people with advanced uveal melanoma (a rare eye cancer) or certain sarcomas (connective tissue cancers). The treatment involves removing immune cells from the patient's tumor, growing them in a lab, an…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug AZD5492 tested for autoimmune diseases in first human study
Disease control Recruiting nowThis Phase 1 trial tests the safety and tolerability of a new drug called AZD5492 in 72 adults with lupus, myositis, or rheumatoid arthritis. Participants receive one or two doses under the skin and are monitored for side effects and how the drug moves through the body. The study…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for kids with tough leukemia: chemo combo trial launches
Disease control Recruiting nowThis early-phase trial is testing a combination of two drugs—Hyper-CVAD chemotherapy and venetoclax—in 22 children and young adults whose leukemia has returned or not responded to treatment. The main goal is to find a safe dose and monitor side effects. If the combination proves …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can reduce the need for blood transfusions and increase red blood cell levels. The study is in earl…
Phase 1/2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a new oral drug take on hard-to-treat leukaemia?
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called AMX-883, taken by mouth, for people with acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to standard treatments. The study will first test AMX-883 alone, th…
Phase 1 • Sponsor: Amphista Therapeutics Ltd • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a simple injection dissolve painful calcium lumps in rare diseases?
Disease control Recruiting nowThis study tests whether injecting sodium thiosulfate directly into abnormal calcium deposits can shrink them and reduce pain. It includes people with three rare conditions: systemic sclerosis, dermatomyositis, and a genetic disorder called iPPSD2. Participants receive up to 11 i…
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill could ease severe childhood arthritis
Disease control Recruiting nowThis study tests a new oral medication, upadacitinib, in children aged 1 to 17 with active systemic juvenile idiopathic arthritis (sJIA), a rare and serious form of arthritis that can affect the whole body. About 90 participants will receive either upadacitinib or the standard in…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Double donor transplant trial aims to boost survival in blood cancer patients
Disease control Recruiting nowThis study tests whether using stem cells from both a half-matched family donor and a cord blood donor can improve survival without cancer returning. It is for people with certain high-risk blood cancers like leukemia or myelodysplastic syndromes. The approach aims to control the…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug takes aim at Treatment-Resistant leukemia
Disease control Recruiting nowResearchers are comparing olverembatinib, an experimental drug, with bosutinib, an approved drug, in adults with chronic phase chronic myeloid leukemia (CML-CP). The trial enrolls patients whose disease has not responded well to at least two prior targeted treatments. A separate …
Phase 3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can acoramidis improve daily life for heart amyloidosis patients?
Disease control Recruiting nowThis study follows 500 adults with transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive heart condition caused by abnormal protein buildup. Participants take acoramidis as part of their usual care, and researchers collect data from hospitals and a European registry. The …
Sponsor: Bayer • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a monthly antibiotic shot keep kids with leukemia safer from infections?
Disease control Recruiting nowThis early-phase trial is testing whether a long-acting antibiotic called dalbavancin, given once every 28 days along with a short course of oral antibiotics, can prevent serious bloodstream infections in children and young adults with high-risk leukemia. The study will enroll 29…
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill takes on tough blood cancers in early trial
Disease control Recruiting nowThis early-stage study tests an oral drug called AUTX-703 in 34 adults with relapsed or hard-to-treat acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The main goal is to check safety and find the right dose. It's an open-label trial, meaning everyone knows they'r…
Phase 1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New injection could ease back pain without surgery
Disease control Recruiting nowThis study tests a one-time injection called VIA Disc NP for people with long-term low-back pain caused by disc disease. The injection adds material to the damaged disc to help cushion it. About 496 adults will receive either the real injection or a sham procedure, and researcher…
Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug tulisokibart aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new medicine called tulisokibart for people with active psoriatic arthritis, a condition causing joint pain and skin plaques. Researchers will compare different doses of the drug to a placebo in 140 adults to see if it improves symptoms like joint tenderness an…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new drug called BGB-11417 (sonrotoclax) in people with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or related blood cancers. The drug works by blocking a protein that helps cancer cells survive. The trial will give the drug alone or toge…
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe and effective for people with advanced head and neck cancer. Ipatasertib may help stop cancer cell growth. About 46 participants will receive the combinati…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug tulisokibart aims to ease back pain and stiffness in ankylosing spondylitis
Disease control Recruiting nowThis study tests whether tulisokibart can improve symptoms of radiographic axial spondyloarthritis, a type of arthritis that causes pain and swelling in the spine and pelvis. About 315 adults with active disease will receive either the drug or a placebo for 16 weeks. Researchers …
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Which root canal paste fights bacteria better?
Disease control Recruiting nowResearchers compare two intracanal medicaments, calcium hydroxide and a calcium silicate-based paste, in 56 adults with acute apical abscesses in single-rooted teeth. They place each medicament inside the cleaned root canal for 7 to 10 days. Bacterial samples are taken before and…
Sponsor: Ataturk University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New immune cell therapy aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis early-phase trial tests whether giving patients a special infusion of donor immune cells (with certain T and B cells removed) after a stem cell transplant is safe and can help prevent their blood cancer from coming back. The study enrolls high-risk patients with hard-to-trea…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for rare blood cancer: targeted drug enters final testing
Disease control Recruiting nowThis study tests a new drug, INCA033989, against the best current treatments for people with a rare blood cancer called essential thrombocythemia who have a specific gene mutation (CALR). About 426 adults who have already tried at least one prior therapy will be randomly assigned…
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo targets tough leukemia in phase II trial
Disease control Recruiting nowThis phase II study is testing a combination of two drugs, enasidenib and azacitidine, in people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The trial enrolls 50 adults with a specific IDH2 gene mutation. The goal is to see if the combinati…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe heart attack (STEMI) and are getting a procedure to open blocked arteries. Participants receive either a single 6-hour infusion of Xolatryp or a placebo, and their heart health is monitored for 30 days. T…
Phase 2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
A balloon that coats heart arteries in drug, no stent left behind
Disease control Recruiting nowResearchers are testing whether a balloon catheter coated with the drug sirolimus can safely open narrowed coronary arteries in adults with heart disease. The balloon inflates to press the drug into the artery wall, aiming to keep the vessel open without leaving a permanent stent…
Sponsor: Tonic Medical, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug MK-1045 enters early human testing for lupus and RA
Disease control Recruiting nowThis early study tests a new medicine, MK-1045, in about 21 people with lupus or rheumatoid arthritis. The main goal is to see if it is safe and tolerable at different dose levels. Participants receive the drug through an IV infusion, and researchers monitor for side effects.
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail targets tough blood cancers
Disease control Recruiting nowThis study tests a combination of three drugs—ivosidenib, venetoclax, and azacitidine—in people with blood cancers like acute myeloid leukemia (AML) that have a specific IDH1 mutation. The goal is to see if the combo is safe and works better than current treatments. About 96 adul…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Robots join the rehab team: a new hope for regaining movement?
Disease control Recruiting nowThis trial tests whether adding robotic rehabilitation devices to standard physiotherapy can improve arm and leg function in adults with movement problems from stroke, spinal cord injury, traumatic brain injury, or orthopedic surgery. Participants will receive robotic-assisted se…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Mayo clinic tests if adding a scope improves hip surgery outcomes
Disease control Recruiting nowThis study compares two surgical approaches for hip dysplasia: the standard periacetabular osteotomy (PAO) alone versus PAO combined with hip arthroscopy. Researchers will enroll 106 people aged 15-55 with mild or no arthritis. The goal is to see if adding arthroscopy leads to be…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for tough leukemia? early trial of debio 1562M begins
Disease control Recruiting nowThis early-phase trial is testing a new drug called Debio 1562M in about 134 people with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The study first checks safety and finds the right dose, then looks at whether the drug can shrink the can…
Phase 1/2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a lower dose of a transplant drug be better for blood cancer patients?
Disease control Recruiting nowThis study is testing whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can prevent graft-versus-host disease (a common complication where donor cells attack the patient's body) while still being effective. The trial involves 260 adults with b…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a robotic suit restore walking after stroke or spinal injury?
Disease control Recruiting nowThis trial tests whether a powered leg exoskeleton called ZEPU AI9 can safely and effectively help people with walking difficulties caused by stroke, incomplete spinal cord injury, or orthopedic surgery. Participants will be randomly assigned to receive either exoskeleton-assiste…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug duo targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called rezatapopt combined with the standard drug azacitidine in 24 adults with a specific type of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has a TP53Y220C mutation. The main goal is to check safety and find the b…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New cord blood transplant recipe aims to beat tough blood cancers
Disease control Recruiting nowThis study tests a standardized, optimized approach to cord blood transplantation for adults with high-risk blood cancers like leukemia and lymphoma. The method includes specific chemotherapy, radiation, and stem cell dosing, followed by careful monitoring. Researchers hope to im…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combo targets tough blood cancers
Disease control Recruiting nowThis phase 2 trial tests a drug called olutasidenib combined with other targeted therapies for people with relapsed or hard-to-treat blood cancers that have a specific IDH1 mutation plus other signaling mutations. The study aims to see how safe and tolerable these drug combinatio…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Robotic leg trainer put to the test for restoring gait after paralysis and surgery
Disease control Recruiting nowThis trial tests whether adding a robotic leg-training device (ZEPU-AI5) to standard rehab can safely improve walking, strength, and balance in adults aged 18–60 with lower-limb problems from stroke, incomplete spinal cord injury, or orthopedic surgery. Participants will receive …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New combo aims to boost lung cancer treatment in patients with bone metastases
Disease control Recruiting nowThis phase 2 trial tests whether adding the drug narlumosbart and precise radiation therapy to standard first-line treatment can help people with advanced non-small cell lung cancer that has spread to the bones. The study will enroll 27 adults who have not had prior systemic ther…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill aims to keep blood cancer away after transplant
Disease control Recruiting nowThis study tests a daily pill called olutasidenib given after a stem cell transplant to people with certain blood cancers (like AML or MDS) that have an IDH1 mutation. The goal is to see if the drug is safe and tolerable as maintenance therapy. About 31 participants will take the…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for psoriatic arthritis sufferers: experimental drug sonelokimab enters final testing phase
Disease control Recruiting nowThis study tests a new drug called sonelokimab for adults with active psoriatic arthritis who have not improved with or cannot take standard TNF-blocker medications. About 600 participants will receive either sonelokimab, a placebo, or an existing drug (risankizumab) for comparis…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a Blood-Derived gel help rebuild bone lost to gum disease?
Disease control Recruiting nowThis study tests whether adding injectable platelet-rich fibrin (i-PRF) to a standard bone graft helps fill in bone defects caused by advanced gum disease. Sixteen adults with stage III periodontitis will receive either the combo treatment or the graft alone during surgery. Resea…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for AML patients in india: drug combo aims for remission without intensive chemo
Disease control Recruiting nowThis study tests a combination of two drugs, venetoclax and azacitidine, in about 100 adults in India with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The goal is to see if the combo can put the cancer into remissio…
Phase 4 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Robot trainer aims to restore walking after neurological injury
Disease control Recruiting nowThis study tests whether a robotic device called ZEPU-AI3 can safely help people with lower limb weakness from stroke, spinal cord injury, or orthopedic surgery improve their walking. Participants receive either standard rehabilitation alone or standard rehab plus robot-assisted …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New Self-Locking biceps repair could reduce popeye deformity after rotator cuff surgery
Disease control Recruiting nowThis trial compares a new self-locking biceps tenodesis technique against a standard method for repairing the biceps tendon during rotator cuff surgery. About 100 adults with full-thickness rotator cuff tears and biceps tendon issues will be randomly assigned to one of the two pr…
Sponsor: Clinique Générale dAnnecy • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New gene therapy trial hopes to restore muscle protein in duchenne boys
Disease control Recruiting nowThis study tests a one-time gene therapy called delandistrogene moxeparvovec in 83 people with Duchenne muscular dystrophy. The goal is to see if it is safe and helps the body make dystrophin, a protein missing in Duchenne. The trial is now enrolling non-ambulatory participants (…
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a robot help people walk again after stroke or injury?
Disease control Recruiting nowThis study tests a robotic device called ZEPU-AI1 that helps people with leg weakness practice standing and walking. The trial includes adults aged 19 to 60 who have walking problems from stroke, spinal cord injury, or orthopedic surgery. Half of the participants will use the rob…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can robots help rebuild movement after stroke or injury?
Disease control Recruiting nowThis trial tests whether robotic devices that guide arm and leg movements can safely improve strength, coordination, and daily function in adults with movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions. Participants will use the devices thre…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combination targets Hard-to-Treat blood cancers
Disease control Recruiting nowResearchers are testing an experimental drug called LP-108, a BCL-2 inhibitor, combined with azacitidine in adults with acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia. The trial aims to find the highest dose people can tolerate and the best …
Phase 1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug aimed at genetic weakness in blood disorders
Disease control Recruiting nowThis study tests a drug called olutasidenib in people with certain early blood conditions (CCUS, lower-risk MDS, or CMML) that have a specific IDH1 gene change. The goal is to see if the drug can control the disease and is safe. About 15 participants will take the drug and be mon…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New triple therapy targets tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs—olutasidenib, decitabine, and venetoclax—in people with acute myeloid leukemia (AML) that has a specific IDH1 gene mutation. The goal is to find a safe and effective dose for those whose cancer has returned or not responded to treatme…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a robotic glove restore hand function after stroke or injury?
Disease control Recruiting nowThis pilot trial asks whether adding a robotic hand-training device to standard rehabilitation is safe, practical, and helpful for people with arm and hand motor problems caused by stroke, incomplete spinal cord injury, traumatic brain injury, or orthopedic conditions. Participan…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could chemo before surgery beat sarcoma? new trial aims to find out
Disease control Recruiting nowThis study is for people with a rare, high-risk cancer called retroperitoneal sarcoma. It compares two approaches: getting chemotherapy before surgery versus surgery alone. The goal is to see if the chemo-first approach helps prevent the cancer from coming back. About 250 partici…
Phase 3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New cartilage patch could help teens with knee damage avoid Long-Term pain
Disease control Recruiting nowThis study tests whether a lab-grown cartilage implant (MACI) works better than a standard surgery (microfracture) for teens aged 10-17 with knee cartilage damage. About 45 participants will receive either treatment and be followed for improvements in pain and sports function. Th…
Phase 3 • Sponsor: Vericel Corporation • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New pill shows promise for rare joint tumor in early trial
Disease control Recruiting nowThis phase 2 trial tests a daily oral drug called pimicotinib in 20 Japanese adults with tenosynovial giant cell tumor (TGCT) that cannot be removed by surgery. The study aims to see if the drug is safe, how it moves through the body, and whether it shrinks tumors. Participants t…
Phase 2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug may boost protein levels in heart disease patients
Disease control Recruiting nowThis study tests whether switching from tafamidis to acoramidis can raise blood levels of transthyretin (TTR) in adults with transthyretin amyloid cardiomyopathy (ATTR-CM). The drug acoramidis stabilizes TTR to prevent harmful amyloid clumps that stiffen the heart. Researchers wi…
Phase 4 • Sponsor: Bayer • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New antibody therapy targets rare blood cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new drug called JNJ-88549968, a bispecific antibody designed to direct the body's immune T cells to attack cancer cells with a specific CALR mutation. The trial will enroll about 220 adults with essential thrombocythemia or myelofibrosis who carry t…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for leukemia patients: experimental drug combo enters late-stage trial
Disease control Recruiting nowThis study tests an experimental drug called BL-M11D1 combined with either standard chemotherapy or another targeted therapy in 216 adults newly diagnosed with acute myeloid leukemia (AML). The goal is to see if the combination is safe and works better at controlling the cancer. …
Phase 2/3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Nose cells could fix your knee: new implant trial launches
Disease control Recruiting nowThis phase II trial tests whether an implant made from a patient's own nasal cartilage can treat patellofemoral osteoarthritis (knee arthritis) better than standard platelet-rich plasma injections. 75 adults aged 18–65 with moderate knee arthritis will be randomly assigned to rec…
Phase 2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
School tooth decay study aims to personalize Kids' dental care
Disease control Recruiting nowThis study tests different sequences of minimally invasive dental treatments—like silver diamine fluoride, sealants, and fluoride varnish—plus a hygiene program, to see which works best for children aged 5 to 13 in schools. The goal is to reduce the number of kids who don't respo…
Phase 3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Engineered immune cells take on autoimmune diseases in first human trial
Disease control Recruiting nowThis early-stage study tests a new treatment called ALLO-329 for people with lupus, myositis, or scleroderma. The therapy uses specially engineered immune cells from a donor to target and calm the overactive immune system. The main goals are to check safety and see if it can impr…
Phase 1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Which dental framework keeps bacteria at bay?
Disease control Recruiting nowResearchers compare two materials for making fixed full-arch dental prostheses supported by four implants in people with no natural teeth in the lower jaw. Each participant receives a prosthesis with either a Zantex (fiber-reinforced polymer) or zirconia (ceramic) framework. The …
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Nature trails may be a new prescription for foot pain
Disease control Recruiting nowThis trial tests whether walking on uneven nature trails in minimalist shoes can strengthen the small muscles of the foot and reduce pain in people with plantar fasciitis. Researchers will compare this nature-walking routine to a standard approach in healthy adults and those with…
Sponsor: University of Florida • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Spinal fluid antibody shots tested for fresh spinal cord injuries
Disease control Recruiting nowResearchers are testing an experimental human monoclonal antibody called NG004 in people who have recently sustained an acute incomplete cervical spinal cord injury. Participants receive repeated injections of NG004 directly into the spinal fluid. The trial's main goal is to chec…
Phase 1 • Sponsor: NovaGo Therapeutics AG • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New spine cage aims to improve back surgery outcomes
Disease control Recruiting nowThis study compares a new spine cage device (MDT-0123) to a standard bone graft for patients needing two-level spinal fusion in the lower back. About 140 adults with disc degeneration or spinal deformity will be enrolled in Japan. The main goal is to see if the device leads to be…
Phase 3 • Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Virtual reality powered by muscle signals could transform stroke rehab
Disease control Recruiting nowThis pilot study tests whether a virtual-reality system controlled by muscle activity can help improve arm and hand movement in people recovering from stroke or spinal cord injury. Participants use a wearable device that detects muscle signals through sensors on the skin and prov…
Sponsor: Imperial College London • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New daily pill shows promise for Long-Term psoriatic arthritis control
Disease control Recruiting nowThis study tests the long-term safety and effectiveness of an oral drug called zasocitinib (TAK-279) in adults with active psoriatic arthritis, a condition causing joint pain and skin patches. About 1,182 participants who completed a one-year parent study will take either a lower…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a targeted pill boost chemo for tough blood cancer?
Disease control Recruiting nowThis Phase 3 trial tests whether adding the drug venetoclax to standard chemotherapy helps adults with newly diagnosed acute myeloid leukemia (AML) or a related high-risk condition. About 650 participants aged 18 to 75 will receive either venetoclax or a placebo alongside chemo. …
Phase 3 • Sponsor: University of Ulm • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with tough leukemia: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study is testing an experimental drug called pivekimab sunirine in about 18 children whose acute myeloid leukemia (AML) has come back or not responded to standard treatments. The main goals are to check the drug's safety and how it moves through the body. Partici…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a new treatment for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to recognize and attack cancer cells…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Second chance: vyxeos targets tough leukemia after standard chemo fails
Disease control Recruiting nowThis study tests a drug called Vyxeos in adults with acute myeloid leukemia (AML) whose cancer did not go away after standard chemotherapy. Vyxeos combines two chemo drugs inside a tiny fat bubble (liposome) to deliver them more effectively. The trial will check for side effects …
Phase 1/2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Heart alert: new study aims to prevent organ damage in sickle cell patients
Disease control Recruiting nowThis study tests whether early heart screening and treatment for iron overload in people with sickle cell disease can prevent heart problems and reduce hospital stays. About 100 adults with sickle cell disease and high iron levels will receive regular heart imaging and follow-up …
Phase 2 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for Still's disease: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new medicine called MAS825 for people with Still's disease, a rare inflammatory condition causing fever, rash, and joint pain. About 20 children and adults with active disease will receive the drug to see if it safely controls symptoms. The goal is to improve d…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody drug takes aim at autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug called SAR448501 (DR-0201) in 62 adults with lupus or rheumatoid arthritis. The drug is a bispecific antibody designed to target the immune system. The main goal is to check safety and find the right dose, not yet to prove it works. Partici…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis pain in major trial
Disease control Recruiting nowThis Phase 3 trial tests whether the experimental drug zasocitinib (TAK-279) can reduce joint swelling and pain in people with active psoriatic arthritis. About 600 adults will receive either the drug or a placebo for up to 60 weeks. The main goal is to see if more people on the …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug combo targets resistant leukemia
Disease control Recruiting nowThis early-stage trial tests a combination of two drugs, gilteritinib and momelotinib, for adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The main goal is to find a safe dose of momelotinib when given with gilteritini…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug trial aims to control arthritis in kids
Disease control Recruiting nowThis study is testing a drug called secukinumab, given as an IV infusion, in 20 children aged 2 to 17 with juvenile psoriatic arthritis. The main goals are to see how the drug moves through the body and to check its safety over up to 6 years. This is an early-stage trial, so it f…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Nanoparticles boost radiation against tough brain tumors
Disease control Recruiting nowThis study tests whether adding AGuIX gadolinium-based nanoparticles to standard brain radiation can better control brain metastases that are at high risk of coming back. About 134 adults with certain cancers (like melanoma, lung, breast, or colorectal) that have spread to the br…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody GEN3018 enters first human tests for tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new antibody drug called GEN3018 in people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has come back or stopped responding to treatment. The main goal is to check safety and find the right dose. Up to 78 parti…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for rare sarcomas: chemo plus immunotherapy combo enters phase III trial
Disease control Recruiting nowThis Phase III trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (doxorubicin) helps people with advanced dedifferentiated liposarcoma or undifferentiated pleomorphic sarcoma live longer without their cancer worsening. About 365 adults whose…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Nano-ink gel could replace repeated skull surgeries for kids with rare genetic disorders
Disease control Recruiting nowThis early-stage study aims to develop a personalized treatment for children with syndromic craniosynostosis, a group of rare genetic disorders where skull bones fuse too early. The approach uses a nano-engineered gel to deliver custom genetic medicine directly to the affected ar…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a robotic suit help kids with neurological conditions walk better?
Disease control Recruiting nowThis trial is testing a robotic exoskeleton called ABLE Kids to see if it is safe and practical for children who have trouble walking due to conditions like cerebral palsy, spinal cord injury, or muscle weakness. Fifteen children will use the device in up to ten one-hour training…
Sponsor: ABLE Human Motion S.L. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a bone marrow injection save young hips after fracture?
Disease control Recruiting nowThis trial tests whether injecting a person's own bone marrow into a hip fracture site helps the bone heal faster and more completely. Adults aged 18 to 55 with a specific type of hip fracture will receive either standard screw fixation alone or screw fixation plus a bone marrow …
Sponsor: Yaser Alkanash • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug could reduce Blood-Letting for polycythemia vera patients
Disease control Recruiting nowThis phase 3 trial tests whether adding the drug sapablursen to standard treatment helps people with polycythemia vera, a blood disorder causing too many red blood cells. About 250 participants who currently need regular blood removal (phlebotomy) will receive either sapablursen …
Phase 3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for stiff lungs? drug trial targets scarring from autoimmune disease
Disease control Recruiting nowThis phase 3 trial tests whether belimumab (Benlysta) can stabilize or improve lung function in adults with interstitial lung disease caused by connective tissue diseases like rheumatoid arthritis or lupus. About 440 participants will receive either belimumab injections or a plac…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a simple knee sleeve slow arthritis and ease pain?
Disease control Recruiting nowThis study tests whether wearing a knee sleeve daily for five years can slow the progression of knee arthritis and reduce pain in adults aged 50 to 64 who have had knee pain for at least three months. Participants are randomly assigned to either wear a knee sleeve every day or no…
Sponsor: Margaret L Gourlay, MD, MPH • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to tame rare childhood leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, trametinib and azacitidine, for children newly diagnosed with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients get just these two drugs, while higher-risk patients also receive standard chemotherapy. Th…
Phase 1/2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Triple drug cocktail targets tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs—ASTX727, venetoclax, and gilteritinib—for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome that has a FLT3 mutation. The drugs work in different ways to stop cancer cells from growing. The trial aims to f…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Shock and shake: new combo therapy aims to rebuild muscle after brain bleed
Disease control Recruiting nowThis study tests whether giving patients electrical muscle stimulation and high-protein shakes soon after a type of stroke (aneurysmal subarachnoid hemorrhage) can prevent muscle loss and improve recovery. Thirty adults will receive the combo therapy or standard care. The main go…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New surgery aims to cut pancreatic leak and diabetes risk
Disease control Recruiting nowThis study tests a surgery called total pancreatectomy with islet autotransplantation (TPIAT) in 30 adults with certain pancreatic tumors who are at high risk for a dangerous leak after standard surgery. The procedure removes the entire pancreas and transplants the insulin-making…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo aims to control rare blood cancer in High-Risk patients
Disease control Recruiting nowThis study tests a combination of two drugs, azacitidine and enasidenib, in people with a high-risk blood cancer called myelodysplastic syndrome (MDS) that has a specific genetic change (IDH2 mutation). The goal is to see if the drugs can stop cancer growth and improve outcomes. …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug trial targets rare genetic heart disease
Disease control Recruiting nowThis early-stage study tests a new medicine called AZD4063 in 31 adults with a specific genetic form of dilated cardiomyopathy (PLN R14del). The main goal is to check the drug's safety and how the body processes it. Participants receive the drug as an injection under the skin and…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Spinal cord zap may help people breathe again after neck injury
Disease control Recruiting nowThis trial tests whether a device that sends mild electrical pulses to the spinal cord can help people with a cervical spinal cord injury breathe more independently. Twenty adults with a C1-C5 injury who need a ventilator will have electrodes implanted near the injury site and re…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Tooth enamel regrown with a gel? a new trial explores a drill-free fix for early decay.
Disease control Recruiting nowThis pilot trial tests a gel called Epinamel that aims to regrow tooth enamel naturally by using minerals from saliva. It includes 20 people who just had their braces removed and have white spot lesions—early signs of decay—on both sides of their mouth. The gel is applied to one …
Sponsor: Mintech Bio Ltd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Experimental drug combo aims to shrink Hard-to-Treat sarcomas
Disease control Recruiting nowThis early-stage trial tests a combination of two drugs—peposertib and a low-dose form of the chemotherapy doxorubicin—in people with advanced sarcomas that have spread or can't be removed by surgery. The goal is to find the safest dose and see if the combo can shrink tumors or s…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Supercharged immune cells take on resistant blood cancers
Disease control Recruiting nowThis study tests a new type of immune cell therapy for people with myeloid cancers (like AML or MDS) that have come back or not responded to treatment. The cells are taken from donated cord blood, engineered to better recognize and attack cancer cells, and given after chemotherap…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Spine disc injection could ease back pain without surgery
Disease control Recruiting nowThis Phase 3 trial tests whether a single injection of IDCT (rebonuputemcel), a cell therapy, can safely reduce pain and disability in people with mild to moderate lumbar disc degeneration. About 162 adults with chronic low back pain will receive either the cell injection or a sh…
Phase 3 • Sponsor: DiscGenics, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Shoulder patch passes safety check in ongoing study
Disease control Recruiting nowThis study is checking the long-term safety and how well a medical device called the Pitch-Patch works for people who have had surgery for a torn rotator cuff in the shoulder. The Pitch-Patch is a small polyester patch that helps strengthen the repair. About 37 people who already…
Sponsor: Xiros Ltd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to tame rare blood disorder flares
Disease control Recruiting nowThis study tests a drug called depemokimab in adults with hypereosinophilic syndrome (HES), a rare condition where too many eosinophils (a type of white blood cell) cause organ damage. The trial includes 123 people whose HES is not well controlled despite standard therapy. Partic…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for kids with tough leukemia: oral drug combo enters human testing
Disease control Recruiting nowThis early-phase trial is testing a combination of two oral drugs—venetoclax and decitabine/cedazuridine—in children and teens whose acute myeloid leukemia (AML) has returned or not responded to prior treatment. The study aims to find the safest dose and check for early signs tha…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new pill rescue patients when standard leukemia drugs stop working?
Disease control Recruiting nowThis phase 3 trial tests the drug radotinib in adults with chronic-phase chronic myeloid leukemia (CML) who have not responded to or could not tolerate earlier treatments such as imatinib. Participants take radotinib twice daily, and researchers measure how well it reduces leukem…
Phase 3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can PET scans reveal if amyloidosis treatment is working?
Diagnosis Recruiting nowResearchers are testing whether beta-amyloid PET/CT scans can detect changes in heart amyloid deposits after one year of treatment for light chain cardiac amyloidosis. Sixty adults with newly diagnosed AL-CA receive standard anti-plasma cell or targeted therapy and undergo PET/CT…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
Folate tracer lights up inflamed hearts in PET scan study
Diagnosis Recruiting nowResearchers at Turku University Hospital are testing a PET imaging tracer called Al[18F]F-NOTA-folate to see how well it detects two heart conditions: cardiac sarcoidosis, an inflammatory disease of the heart muscle, and infective endocarditis, an infection of the heart valves. T…
Sponsor: Turku University Hospital • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
Can AI learn to spot endometriosis and fibroids on ultrasound?
Diagnosis Recruiting nowResearchers at Semmelweis University are building and testing artificial intelligence algorithms that read standardized transvaginal ultrasound images. The study includes women aged 18 to 45 who have suspected endometriosis or adenomyosis, a confirmed uterine mass scheduled for s…
Sponsor: Semmelweis University • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can advanced imaging reveal hidden swallowing muscle damage in IBM?
Diagnosis Recruiting nowResearchers at Johns Hopkins University are studying whether neuromuscular ultrasound and MRI can serve as reliable markers of swallowing muscle problems in people with inclusion body myositis (IBM). The study compares imaging and clinical findings in 30 participants, including p…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
5-Minute MRI could solve brain tumor mystery after radiation
Diagnosis Recruiting nowThis study is testing a new, quick MRI technique called Magnetic Resonance Fingerprinting (MRF) to better tell the difference between a brain tumor coming back and damage from radiation therapy (radiation necrosis). About 90 people will take part, including healthy volunteers, pa…
Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
New PET tracer could spot hidden heart scarring in rare amyloidosis
Diagnosis Recruiting nowThis study tests a special radioactive tracer called [68Ga]Ga-FAPI-46 for PET scans in 40 people with transthyretin cardiac amyloidosis (ATTR-CM), a condition where abnormal proteins build up in the heart. The goal is to see if this scan can measure scar-like activity in the hear…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
New scanner could help surgeons pinpoint the right discs to treat
Diagnosis Recruiting nowThis study tests a tool called NOCISCAN that uses a special type of MRI to find which discs in the lower back are causing pain. About 300 adults who are already planning back surgery will take part. Half of the surgeons will see the NOCISCAN results, and half will not, to see if …
Sponsor: Aclarion • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can two simple questionnaires capture how bad sinus disease feels?
Diagnosis Recruiting nowResearchers at 32 medical centers in Europe, the USA, and South Africa are testing two new questionnaires designed to measure how severe chronic rhinosinusitis feels and how well it is controlled. About 1,000 patients with chronic rhinosinusitis, with or without nasal polyps, fil…
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
A new brain scan tracer aims to light up myelin damage
Diagnosis Recruiting nowResearchers at Yale University are testing a PET imaging tracer called [18F]3F4AP to see whether it can measure demyelination, the loss of the protective myelin sheath around nerve fibers. The study includes healthy volunteers and people with conditions such as multiple sclerosis…
Phase 1 • Sponsor: Yale University • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New screening tool aims to catch hidden arthritis in psoriasis patients
Diagnosis Recruiting nowThis Canadian study tests whether adding two questions about morning stiffness and lower back pain to a standard screening tool (PEST) can help dermatologists identify psoriatic arthritis earlier in people with moderate-to-severe plaque psoriasis. About 502 adults who are candida…
Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Can AI predict your lifespan from a short video?
Diagnosis Recruiting nowResearchers are building AI models that score standard physical and cognitive screening tests from video and audio, and that predict results a person did not obtain. The study enrolls adults 18 and older and follows them for life, linking records to a long-term aging study to che…
Sponsor: Longevity Metrics, Inc. • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New PET tracer aims to spot hidden amyloid deposits
Diagnosis Recruiting nowThis study is testing a new imaging agent called [18F]FT8 to see if it can help doctors better see and diagnose amyloidosis, a disease where abnormal proteins build up in organs like the heart. The study will involve 20 patients with amyloidosis and 5 healthy volunteers. Research…
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Poop pills to prevent transplant rejection? new trial tests fecal transplants in blood cancer patients
Prevention Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can prevent graft-versus-host disease (GvHD) in 150 adults with blood cancers who receive a stem cell transplant. Patients get a single FMT enema within four weeks of transplant. The main goal is to see if FMT improves …
Phase 2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
Can a simple wash stop the bacteria behind shoulder surgery infections?
Prevention Recruiting nowResearchers are testing whether washing the surgical site with antimicrobial solutions after the first cut lowers the amount of Cutibacterium acnes, a bacterium commonly found on the skin, during shoulder replacement surgery. Adults scheduled for a first shoulder replacement are …
Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Jawbone rescue: can a Blood-Based membrane save your smile after a tooth comes out?
Prevention Recruiting nowWhen a tooth is removed, the jawbone underneath can shrink, which may make it harder to place a dental implant later. This trial tests two methods to limit that bone loss: one uses a bone graft plus a membrane made from the patient's own blood (platelet-rich fibrin), and the othe…
Sponsor: Danae A. Apatzidou • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Chewing gum to prevent premature births? major trial underway in malawi
Prevention Recruiting nowThis study tests whether chewing xylitol gum during pregnancy can reduce the risk of preterm birth and low birthweight. 6,000 pregnant women in Malawi will chew either a high or low dose of xylitol gum or a placebo gum. The goal is to see if improving oral health with xylitol lea…
Phase 2/3 • Sponsor: University of Washington • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Pill vs shot: testing a simpler way to stop deadly clots after spinal cord injury
Prevention Recruiting nowPeople who suffer spinal cord injuries face a high risk of dangerous blood clots, and doctors usually prescribe enoxaparin, a daily injection, to prevent them. This trial compares enoxaparin with apixaban, an oral blood thinner, in 60 adults recovering from spinal cord injury at …
Sponsor: Loewenstein Hospital • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Sugar compound in dental wipes may shield kids with leukemia from deadly infections
Prevention Recruiting nowThis phase 3 trial tests whether xylitol dental wipes can reduce bloodstream infections in children with acute myeloid leukemia (AML). Xylitol, a natural sugar that limits mouth bacteria growth, is applied via wipes during chemotherapy. The study will compare infection rates betw…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Can a lingzhi mushroom pill lift the fog of Long-Lasting fatigue?
Symptom relief Recruiting nowResearchers are testing whether a Lingzhi-containing dietary supplement called CP003 reduces fatigue in people with chronic fatigue syndrome or persistent fatigue after COVID-19. The study compares people who take the supplement for six weeks with those who wait to start treatmen…
Phase 2/3 • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Robots and VR join the fight to recover from nerve and muscle diseases
Symptom relief Recruiting nowThis study compares a high-tech rehabilitation program—using robotic systems, virtual reality, and balance platforms—to standard physical therapy for people with acute neuromuscular diseases like Guillain-Barré syndrome. About 124 adults aged 18 to 80 will participate. The goal i…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Acupuncture vs. pills: which works better for slipped discs?
Symptom relief Recruiting nowThis study compares non-drug treatments (acupuncture, spinal manipulation) with standard medications (painkillers, injections) for people with a herniated disc in the lower back who have had pain for at least a month. 200 adults aged 19-69 will be randomly assigned to one of the …
Sponsor: Jaseng Medical Foundation • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Taping techniques face off in knee pain trial
Symptom relief Recruiting nowPatellofemoral pain syndrome causes knee pain during activities like squatting or climbing stairs. This trial compares two taping methods, McConnell and Kinesio, each combined with a four-week hip and knee strengthening program. Thirty-four adults aged 26 to 44 with this knee pai…
Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can robotic surgery personalize knee replacement?
Symptom relief Recruiting nowResearchers compare standard knee replacement surgery with robotic-assisted surgery that uses patient-specific alignment in people with knee osteoarthritis. Participants receive one of three surgical approaches and are followed for a year to measure implant position, inflammation…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Nerve block strategy tested to prevent chronic pain after knee replacement
Symptom relief Recruiting nowResearchers compare two regional anesthesia approaches for people having total knee replacement. One approach uses a fast-track protocol, while the other uses continuous infusions through femoral and sciatic catheters. The trial measures whether the continuous catheter method red…
Sponsor: Policlinico di Monza SpA • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Platelet injections face off against placebo for knee arthritis
Symptom relief Recruiting nowResearchers compare two platelet-based injections, platelet lysate and platelet-rich plasma, against a saline placebo in adults aged 50 to 80 with mild to moderate knee osteoarthritis. Participants receive one injection into the knee and researchers track pain, joint function, X-…
Phase 4 • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can a common gout pill ease pain from this rare joint disease?
Symptom relief Recruiting nowThis study tests whether colchicine, a drug used for gout, can lower inflammation and pain in people with CPPD disease. About 150 adults will take either colchicine or a placebo daily for 6 months. Researchers will measure blood markers and joint symptoms to see if the drug helps…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Could a pinch of radiation ease arthritis pain?
Symptom relief Recruiting nowThis study investigates whether low-dose radiation therapy (LDRT) can reduce pain and improve function in people with osteoarthritis of the hips, knees, hands, shoulders, ankles, or elbows. Participants who have not responded to standard treatments will receive one or two courses…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
New hip implant put to the test in arthritis patients
Symptom relief Recruiting nowResearchers are studying a new hip replacement device called the HIT Hip Replacement System in people aged 65 to 79 with hip arthritis. The trial measures how well the device improves pain and function over two years using patient questionnaires and X-rays. It also tracks safety …
Sponsor: Hip Innovation Technology • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
New dental glue could zap tooth pain instantly
Symptom relief Recruiting nowThis study tests whether a special adhesive filled with strontium-doped bioactive glass-ceramic can reduce tooth sensitivity. 142 adults with sensitive teeth will receive a single application of either the new adhesive or a standard one. Pain levels will be checked right after an…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can a robot make a new knee feel like your own?
Symptom relief Recruiting nowThe ROCKETS trial compares robot-assisted total knee replacement with conventional total knee replacement in adults with knee osteoarthritis. Researchers randomly assign up to 1,600 participants to one of the two surgical approaches and follow them for two years. The main questio…
Sponsor: Danderyd Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can pressing these points ease knee pain? new study tests DIY acupressure for seniors
Symptom relief Recruiting nowThis study tests whether teaching older adults to press specific points on their body (self-administered acupressure) can reduce knee osteoarthritis pain. About 368 Chinese adults aged 60+ with knee pain will learn the technique in two sessions and practice at home. Researchers w…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can virtual visits replace In-Person pain care for rural patients?
Symptom relief Recruiting nowThis study tests whether virtual lifestyle-focused pain care works as well as in-person care for adults with chronic back, knee, or hip pain living in rural areas. Participants will receive up to 10 sessions over six months, either in-person with a physiotherapist or virtually wi…
Sponsor: University of Sydney • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New nasal spray aims to ease sinus troubles in teens
Symptom relief Recruiting nowThis study tests whether a nasal spray called OPN-375 can reduce symptoms of chronic sinusitis (like stuffy nose, discharge, and facial pain) in adolescents aged 12 to 17. About 84 teens will receive either the spray or a placebo twice daily for 12 weeks. The main goal is to see …
Phase 3 • Sponsor: Optinose US Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Massive pain trial aims to find new relief options
Symptom relief Recruiting nowThis Phase 2 trial is testing four experimental drugs (taken orally or by IV) against placebo in 10,000 people with chronic pain from knee osteoarthritis, diabetic nerve damage, or low-back pain. The goal is to see if any of these drugs can safely reduce pain. The study uses a fl…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves zap knee pain without needles
Symptom relief Recruiting nowThis study tests a device that uses focused sound waves to block pain signals in the knee, offering a needle-free option for people with chronic osteoarthritis pain. Ten adults with moderate to severe knee pain will receive a one-hour treatment and be followed for six months. The…
Sponsor: FUSMobile Inc. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can your own blood and fat heal aching joints? new trial aims to find out
Symptom relief Recruiting nowThis early-phase trial will test four orthobiologic treatments—PRP, bone marrow concentrate, hyaluronic acid, and nanofat—in 300 adults with various muscle, joint, tendon, or bone conditions. The goal is to see if these natural substances can reduce pain and improve joint functio…
Early phase 1 • Sponsor: PROREGEN • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New knee shot aims to ease arthritis pain without surgery
Symptom relief Recruiting nowThis study tests a new injection called CartiPRO to see if it can safely reduce knee pain in people with osteoarthritis. About 194 adults will receive either CartiPRO or another approved injection, and then get a second shot 24 weeks later. Researchers will measure pain and knee …
Sponsor: DALIM TISSEN Co., Ltd. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can mirror therapy and action observation rewire the brain to ease shoulder pain?
Symptom relief Recruiting nowResearchers are testing whether a 12-week program that combines movement representation techniques with sensorimotor training can reduce shoulder pain in adults aged 50 and older who have had rotator cuff related shoulder pain for more than three months. The program uses action o…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New needle technique aims to ease back pain in ankylosing spondylitis
Symptom relief Recruiting nowThis study tests a new, ultrasound-guided acupotomy technique to improve symptoms in people with ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 60 adults with active disease will receive the treatment to see if it reduces pain and improves …
Sponsor: China-Japan Friendship Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
A 3D-Printed bone replica could save the ankle joint
Symptom relief Recruiting nowAvascular necrosis of the talus happens when the ankle bone loses its blood supply and collapses. Researchers are testing a custom-made implant shaped like the patient's own talus to replace the damaged bone. The study follows 50 adults for five years to see whether the implant r…
Sponsor: Paragon 28 • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Which anesthesia gets you home faster after shoulder surgery?
Symptom relief Recruiting nowThis study compares two types of anesthesia for rotator cuff repair surgery: general anesthesia combined with local anesthesia versus local anesthesia alone. The goal is to see which approach leads to faster recovery and readiness to leave the recovery room. About 34 adults with …
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could CBD help spinal cord injury patients regain bladder control?
Symptom relief Recruiting nowThis study tests whether cannabidiol (CBD), a compound from cannabis, can reduce urinary incontinence in people with recent spinal cord injury. Twenty adults with at least two leaks per day will take a purified CBD drug (Epidiolex) twice daily for 90 days. The main goal is to see…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Gender-Sensitive therapy: a new hope for knee osteoarthritis?
Symptom relief Recruiting nowThis study tests a 6-week physiotherapy program designed to improve pain, function, and joint awareness in adults with knee osteoarthritis. The program uses sensory modulation and graded weight-bearing exercises, and the trial compares outcomes between male and female participant…
Sponsor: Shifa Tameer-e-Millat University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Lavender massage may soothe arthritis pain, new study says
Symptom relief Recruiting nowThis study tests whether adding lavender aromatherapy massage to standard care can reduce pain and improve wrist movement in people with rheumatoid arthritis. About 100 adults with stable medication will be randomly assigned to get the massage or not. Researchers will measure pai…
Sponsor: University of Baghdad • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New gel injection aims to soothe sore tendons
Symptom relief Recruiting nowThis study is testing a gel called OSTENIL TENDON to see if it safely reduces pain and improves movement in people with tendon problems. Researchers will enroll 84 adults with one of four types of tendinopathy. The main goal is to measure pain changes three months after treatment…
Sponsor: TRB Chemedica AG • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Spinal implant aims to restore bladder control after paralysis
Symptom relief Recruiting nowResearchers are testing whether epidural electrical stimulation can improve bladder function in people with spinal cord injuries. The trial enrolls adults with injuries above T11 who have trouble urinating and rely on catheters. Participants receive an implanted spinal cord stimu…
Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
A new ankle? researchers track 400 people with an implant meant to restore movement
Symptom relief Recruiting nowResearchers are studying the Exactech Vantage Mobile-Bearing Total Ankle System, an implant used to replace a damaged ankle joint. The study enrolls 400 adults with ankle arthritis or related joint failure who are scheduled for total ankle replacement. Participants receive the im…
Sponsor: Exactech • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a new ankle implant keep people moving for a decade?
Symptom relief Recruiting nowResearchers are studying the Exactech Vantage Total Ankle System, an implant used to replace a damaged ankle joint in people with arthritis or a failed previous replacement. The study enrolls 370 adults who are candidates for total ankle replacement and follows them for up to 10 …
Sponsor: Exactech • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a nasal spray help spinal cord injury? new safety trial begins
Symptom relief Recruiting nowThis early-stage study is checking if insulin nasal spray is safe for people with spinal cord injury. Up to 12 adults who had an injury at least 4 months ago will use the spray or a placebo daily for up to 24 days. Researchers will monitor side effects and see if virtual training…
Phase 1 • Sponsor: HealthPartners Institute • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Hip surgery pain targeted with nerve block in new trial
Symptom relief Recruiting nowResearchers are testing whether a nerve block called a PENG block reduces pain after periacetabular osteotomy, a major hip realignment surgery. In the study, 90 adults scheduled for this surgery receive either ropivacaine, a local anesthetic, or a saline placebo injected around s…
Phase 4 • Sponsor: Matias Vested • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Brain training for the spine: new study aims to reduce spasticity and boost walking
Symptom relief Recruiting nowThis study tests a behavioral training program that teaches people with chronic spinal cord injury to reduce a specific leg reflex. The goal is to decrease spasticity and improve walking speed and distance. 25 participants will train for about 6 months, with researchers measuring…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New app aims to ease mental strain for veterans with spinal injuries and their families
Symptom relief Recruiting nowThis study tests a mobile health app called iMHere 2.0 designed to help veterans with spinal cord injury and their family caregivers manage stress and improve well-being. Researchers will work with 100 participants to gather feedback and tailor the app to their needs. The goal is…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Shockwave therapy could ease stubborn neck pain
Symptom relief Recruiting nowThis pilot study tests whether focused shockwave therapy can reduce pain and improve function in people with chronic neck and shoulder muscle pain. Sixty adults will be randomly assigned to receive either three weekly shockwave sessions or a home exercise program. Researchers wil…
Sponsor: Cishan Hospital, Ministry of Health and Welfare • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
CBD trial aims to ease sanfilippo syndrome symptoms
Symptom relief Recruiting nowThis study tests whether cannabidiol (CBD) can safely improve behavior, mood, sleep, and daily function in people with Sanfilippo syndrome, a rare genetic disorder. Thirty-five participants will receive either CBD or a placebo, then switch after a break. Caregivers will report on…
Phase 2/3 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can talk therapy and symptom tracking ease the trauma of leukemia?
Symptom relief Recruiting nowThis study tests a program called EASE that combines psychological support with regular symptom checks and early access to palliative care. Researchers want to see if it reduces traumatic stress and physical symptoms in people newly diagnosed with acute leukemia. Half of the 266 …
Sponsor: Canadian Cancer Trials Group • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New twist on old muscle relaxant aims to ease sciatica pain in days
Symptom relief Recruiting nowThis study tests whether a modified version of the muscle relaxant metaxalone (640 mg) can reduce low back and leg pain in people with acute sciatica or spinal stenosis. Fifty adults aged 18 to 80 with new-onset pain will take either the drug or a placebo for 7 days. Researchers …
Phase 4 • Sponsor: Primus Pharmaceuticals • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Recruiting nowThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase 2/3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Knee replacement pain showdown: local injection vs nerve blocks
Symptom relief Recruiting nowThis study compares two pain relief methods for people undergoing total knee replacement: injecting numbing medicine into the knee area versus blocking several nerves around the knee. The goal is to see which method reduces the need for strong painkillers like opioids in the firs…
Sponsor: CMC Ambroise Paré • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Does the order of bone grafting change how well dental implants take?
Symptom relief Recruiting nowResearchers compare two ways of sequencing bone grafting during sinus lift and dental implant placement in the upper jaw. One sequence places the implant before packing bone graft; the other packs the graft first, then drills for the implant. Both use a customized surgical guide …
Sponsor: Cairo University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Robot vs surgeon: which knee replacement works better?
Symptom relief Recruiting nowThis study compares two types of total knee replacement surgery for people with knee osteoarthritis: one done manually and one assisted by a robotic device (VELYS). About 346 participants will be randomly assigned to one of the two surgeries and followed for a year to see which l…
Sponsor: Golden Jubilee National Hospital • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Pure oxygen tested as a switch for dormant nerves after spinal cord injury
Symptom relief Recruiting nowResearchers at the University of Alberta are testing whether breathing pure oxygen for two minutes at a time can change sensation and movement in adults with long-standing, severe spinal cord injuries. The study enrolls 25 people aged 18 to 65 whose injuries occurred at least thr…
Early phase 1 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
New pacing technique aims to outperform standard therapy for heart failure
Symptom relief Recruiting nowResearchers are testing whether a pacing technique called left bundle branch area pacing, guided by detailed imaging and electrical data, can improve outcomes for people with heart failure and left bundle branch block. The trial enrolls 100 adults with non-ischemic cardiomyopathy…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can spinal stimulation plus intense training help children injured at birth move better?
Symptom relief Recruiting nowResearchers at the University of Louisville are studying children who have a cervical spinal cord injury that happened before or during birth. The study combines activity-based recovery training, which uses tasks like stepping and standing, with transcutaneous spinal cord stimula…
Sponsor: University of Louisville • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can fewer acupuncture sessions tame chronic heel pain?
Symptom relief Recruiting nowResearchers are comparing two schedules of electroacupuncture for adults with chronic plantar fasciitis, a common cause of heel pain. Participants receive either one session per week or three sessions per week for four weeks. The trial measures whether at least half of participan…
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Lower back nerve block tested to cut pain after fibroid surgery
Symptom relief Recruiting nowResearchers are testing whether a quadratus lumborum nerve block reduces pain after laparoscopic myomectomy, a surgery to remove uterine fibroids while keeping the uterus. The block is a temporary anesthetic injection into a lower back muscle. In this double-blind, randomized tri…
Phase 4 • Sponsor: Joseph Findley MD • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Could bunion surgery patients walk right away? trial puts it to the test
Symptom relief Recruiting nowResearchers are testing whether people can put full weight on the foot immediately after a modified Lapidus operation, a common bunion surgery that fuses bones in the midfoot. The trial assigns 122 adults to either walk fully in a special post-op shoe or limit weight to 10 to 15 …
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can adding Shoulder-Blade training boost neck pain relief?
Symptom relief Recruiting nowResearchers are testing two physical therapy approaches for adults aged 40 to 60 with chronic neck pain and confirmed cervical spondylosis. Both groups do deep neck flexor training guided by a pressure biofeedback device, and one group also adds shoulder-blade stabilization exerc…
Sponsor: Ibadat International University, Islamabad • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Steroid shots during knee replacement: which route works best?
Symptom relief Recruiting nowResearchers are testing whether giving the steroid dexamethasone during total knee replacement helps with pain, nausea, and recovery, and whether it matters if the drug goes into a vein or is injected around the knee joint. The trial enrolls 159 adults with knee osteoarthritis ha…
Phase 4 • Sponsor: Christian Candrian • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Pre-transplant workout may shield heart in older leukemia patients
Symptom relief Recruiting nowThis study tests a home-based exercise program called CAREFit-BMT for people with high-risk acute myeloid leukemia who are about to have a stem cell transplant. The program includes aerobic and strength training to improve heart function before the procedure. Researchers will enr…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Dentists test three sealers to find the most comfortable root canal
Symptom relief Recruiting nowThis study compares three different root canal sealers—AH Plus, ProRoot Bio Sealer, and BC Sealer ion+—to see which one leads to the least pain after treatment. About 135 adults with irreversible pulpitis in a lower molar will be randomly assigned to one of the three sealers. Pat…
Sponsor: European University of Lefke • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can collagen shots around the heel tendon speed recovery?
Symptom relief Recruiting nowAchilles tendinopathy is a painful condition of the tendon at the back of the ankle. Researchers are testing whether injecting a collagen-based medical device around the tendon, combined with a physiotherapy program of eccentric strengthening exercises, improves pain and function…
Sponsor: Guna S.p.a • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Natural annatto compound tested for statin muscle aches
Symptom relief Recruiting nowThis study tests whether a supplement called geranylgeraniol (GG), derived from annatto seeds, can reduce muscle pain and weakness caused by statin medications. Researchers will give 95 adults either a low or high dose of GG or a placebo for three months. The goal is to see if GG…
Phase 1/2 • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Mapping the Heart's hidden short circuits: a new ablation strategy for dangerous rhythms
Symptom relief Recruiting nowResearchers are testing a targeted ablation method for people with structural heart disease who have ventricular tachycardia, a dangerous fast heart rhythm. The procedure maps conducting channels inside heart scar tissue by pacing many sites, then uses radiofrequency energy to bl…
Sponsor: New York Medical College • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Knee replacement pain relief showdown: which numbing cocktail wins?
Symptom relief Recruiting nowThis study tests three different numbing medicine combinations for pain after total knee replacement. 90 adults having knee surgery will get one of three options: a long-acting numbing drug, or a standard numbing drug plus one of two additives. The goal is to see which approach r…
Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could an Anti-Gravity treadmill make knee arthritis physiotherapy work better?
Symptom relief Recruiting nowResearchers are testing whether adding gait re-education on an R-Force anti-gravity treadmill to standard physiotherapy helps adults with knee osteoarthritis. The trial enrolls 80 people aged 40 to 70 who have radiologically confirmed knee arthritis and ongoing knee pain. Partici…
Sponsor: University of Rzeszow • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Sinus surgery without opioids: can dexmedetomidine do the job?
Symptom relief Recruiting nowResearchers are studying whether skipping opioids during functional endoscopic sinus surgery leads to better recovery. The trial follows 104 adults with chronic sinusitis who receive anesthesia with dexmedetomidine and other non-opioid pain relievers instead of standard opioid dr…
Sponsor: Filiz Kaya • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New thumb implant could speed recovery from arthritis surgery
Symptom relief Recruiting nowThis study compares two surgical treatments for rhizarthrosis, a type of arthritis at the base of the thumb. One group gets a new prosthesis (HORUS implant), the other gets the standard trapezectomy. Researchers will measure hand function and pain in 50 patients over the short te…
Sponsor: Clinique Bizet • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a leg nerve zap help kids with spina bifida go Drug-Free?
Symptom relief Recruiting nowThis study tests a small, home-use device that sends mild electrical pulses to a nerve in the leg (tTNS) to improve bladder control in 20 children with spina bifida who have neurogenic bladder. Half the kids will use the real device, half a sham device, for 30 minutes daily, 5 da…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New combo therapy aims to ease knee pain without heavy lifting
Symptom relief Recruiting nowThis study tests whether combining blood-flow-restricted exercise (light exercise with a cuff on the leg) and pain education can reduce pain and improve movement in people with knee osteoarthritis. About 90 adults aged 40 and older with knee osteoarthritis will take part. The goa…
Sponsor: University of Hail • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
A shot to straighten a smile: botulinum toxin tested in kids with facial asymmetry
Symptom relief Recruiting nowThis trial tests whether botulinum toxin type A injections can improve lower-lip asymmetry in children with hemifacial microsomia, a condition where the lower lip moves unevenly during smiling or speaking. The study enrolls children under 18 with this condition and a crooked-mout…
Sponsor: Peking Union Medical College • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Frozen shoulder patients may get relief by working out the other arm
Symptom relief Recruiting nowThis study tests whether cross training—exercising the healthy arm—can improve pain, function, and mobility in people with frozen shoulder, without directly working the painful shoulder. About 38 adults aged 18-65 with unilateral frozen shoulder will be randomly assigned to stand…
Sponsor: Inonu University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New electrode design may extend pain relief for common back condition
Symptom relief Recruiting nowThis study tests whether a newer multi-tined electrode provides longer pain relief than a standard single-tip electrode during radiofrequency ablation for lumbar spondylosis, a common cause of lower back pain. About 25 adults with chronic lower back pain from worn facet joints wi…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can physical therapy beamed into rural homes ease arthritis pain?
Symptom relief Recruiting nowResearchers at the University of Alberta are comparing two virtual physical therapy programs with usual care for rural adults who have hip or knee osteoarthritis and are not waiting for joint replacement surgery. Participants first continue their usual arthritis care for 12 weeks…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Surgeons test augmented reality to Fine-Tune knee replacement cuts
Symptom relief Recruiting nowResearchers are testing whether an augmented reality guidance system helps surgeons make more accurate bone cuts and align knee implants during total knee replacement. The study enrolls about 50 adults with advanced osteoarthritis who are scheduled for a primary knee replacement …
Sponsor: Foundation for Orthopaedic Research and Education • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Brain retraining trial aims to ease chronic fatigue and long COVID symptoms
Symptom relief Recruiting nowThis study is testing a mind-body program called DNRS for people with ME/CFS (chronic fatigue syndrome) who may also have Long COVID. The program uses brain retraining to help calm overactive nerves and improve symptoms like fatigue, pain, and mood. Researchers will track quality…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Bone marrow injection may offer longer hip pain relief than steroids
Symptom relief Recruiting nowThis study tests whether a single injection of concentrated bone marrow cells can reduce pain and improve function in people with hip osteoarthritis better than a standard steroid injection. One hundred adults with moderate to severe hip arthritis will be randomly assigned to rec…
Phase 3 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Simple leg workouts may ease knee pain and improve sleep
Symptom relief Recruiting nowThis study tests whether a program that strengthens the quadriceps and calf muscles can improve walking, reduce pain, and enhance sleep in people with knee osteoarthritis. About 52 adults aged 40-60 with moderate knee arthritis will be randomly assigned to either the exercise pro…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Fish or puppets: which distraction works best for needle-phobic kids?
Symptom relief Recruiting nowThis trial tests whether two simple distractions — watching a betta fish or playing with a hand puppet — can lower pain, fear, and anxiety in children aged 5 to 7 during a blood draw. One group will use the fish, another the puppet, and a third will receive standard care. Researc…
Phase 1 • Sponsor: Igdir University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a Flat-Sided dental file mean less pain after a root canal?
Symptom relief Recruiting nowResearchers at Minia University are testing whether the shape of a single-file rotary dental instrument affects how much debris gets pushed out of the root tip during a root canal, and whether that changes how much pain patients feel afterward. Thirty teeth with irreversible pulp…
Sponsor: Minia University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Could a simple mist replace needles for kids' post-surgery pain?
Symptom relief Recruiting nowThis study tests whether giving a numbing medicine (bupivacaine) as a mist before surgery can lower pain and the need for extra painkillers in children aged 1-7 having cleft palate repair. Half the children get the mist, half get a placebo, and neither the doctors nor families kn…
Phase 3 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Sugar water vs. anesthetic: which injection eases knee arthritis best?
Symptom relief Recruiting nowThis study will follow 86 adults with knee osteoarthritis to see if injections of sugar-water (dextrose) or local anesthetic around the knee nerves provide better pain relief and function. Participants will be assessed for six months after their routine injection. The goal is to …
Sponsor: Ankara Training and Research Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Skin-Deep spinal stimulation: can zapping the spine help people walk again?
Symptom relief Recruiting nowResearchers at the University of Washington are testing whether non-invasive electrical stimulation of the spinal cord through the skin, combined with intensive physical therapy, can improve walking and standing in people with spinal cord injuries. The trial enrolls 20 adults wit…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Steroid shot before shoulder replacement may cut pain and hospital time
Symptom relief Recruiting nowThis study tests whether giving a steroid (dexamethasone) during shoulder replacement surgery can improve recovery. Researchers will measure pain, nausea, shoulder movement, and how long patients stay in the hospital. The study involves 74 adults with shoulder arthritis who are h…
Phase 4 • Sponsor: Christian Candrian • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New study pits two back pain injections Head-to-Head
Symptom relief Recruiting nowThis study compares two common injection treatments for chronic mid-back pain: the erector spinae plane (ESP) block and trigger point injection (TPI). About 76 adults with pain lasting at least three months will be randomly assigned to one treatment. Researchers will track pain l…
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New daily pill could ease knee pain and help weight loss in obesity
Symptom relief Recruiting nowThis study tests a once-daily pill called orforglipron in 800 adults with obesity or overweight who also have painful knee osteoarthritis. The goal is to see if the drug reduces knee pain and improves physical function over about 74 weeks. Participants will be randomly assigned t…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New weekly shot aims to ease arthritic knee pain and shed pounds
Symptom relief Recruiting nowThis Phase 3 study tests a once-weekly injection called eloralintide in 900 adults with osteoarthritis of the knee who are also overweight or obese. The goal is to see if it reduces knee pain and helps with weight loss compared to a placebo. Participants will be in the study for …
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New pill could ease osteoarthritis knee pain without surgery
Symptom relief Recruiting nowThis Phase 2 trial tests an experimental oral drug, LY4065967, for knee pain caused by osteoarthritis. About 150 adults with chronic knee pain and confirmed osteoarthritis will receive either the drug or a placebo. The main goal is to see if the drug safely reduces pain intensity…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Inside or outside the knee: which steroid injection spot eases arthritis pain better?
Symptom relief Recruiting nowThis trial compares two injection sites for steroid shots in people with moderate-to-severe knee osteoarthritis. Participants get the injection on either the inside or outside of the knee, then report pain and function over 12 weeks. The goal is to see if one spot provides better…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a Screen-Based tai chi class soothe aching knees?
Symptom relief Recruiting nowThis trial tests whether remote tai chi, taught through web-based sessions twice a week for 12 weeks, can reduce knee pain in adults aged 50 and older with knee osteoarthritis. Researchers compare adding remote tai chi to routine care against routine care alone, measuring pain, p…
Sponsor: Tufts Medical Center • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a smart platform ease the toll of childhood cancer on families?
Symptom relief Recruiting nowThis trial tests two digital platforms, one for children with cancer and one for their parents, designed to improve communication with healthcare providers and address physical, emotional, social, and spiritual needs during treatment. Researchers will recruit 120 families of chil…
Sponsor: National Defense Medical University, Taiwan • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can cannabis compounds ease arthritic knees? new trial aims to find out
Symptom relief Recruiting nowThis phase 2 trial is testing whether daily doses of THC, CBD, or both can reduce pain and improve symptoms in people with knee osteoarthritis. About 200 participants will take one of the study drugs or a placebo for 16 weeks, with regular pain assessments, blood tests, and brain…
Phase 2 • Sponsor: Steven E Harte, PhD • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Could your environment trigger this rare muscle disease?
Knowledge-focused Recruiting nowThis study investigates whether certain environmental exposures—like infections, stress, or sun exposure—are more common in people with anti-synthetase syndrome, a rare autoimmune condition that causes muscle weakness and lung disease. Researchers will compare 580 participants, i…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Alzheimer's drug donepezil may help prevent fractures, study suggests.
Knowledge-focused Recruiting nowThis study looks at whether donepezil, a common Alzheimer's medication, can improve bone density and reduce fracture risk in older adults with mild to moderate Alzheimer's. Researchers will compare donepezil to another drug, memantine, over 12 months in 45 participants. The goal …
Phase 2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Jumping Athletes' knee health: new study spots trouble early
Knowledge-focused Recruiting nowThis study looks at how athletes at risk for patellar tendinopathy (jumper's knee) move during jumps. Researchers will use a camera system to track knee, hip, and ankle angles in 60 male athletes over 12 months. The goal is to find early movement changes that could lead to better…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
800-Patient registry maps the hidden path of rare muscle and heart gene disorders
Knowledge-focused Recruiting nowLaminopathies and emerinopathies are rare disorders caused by mutations in the LMNA or EMD genes, often affecting skeletal muscles and the heart. Researchers at French hospitals are building a registry of 800 patients with confirmed mutations to record detailed genetic, neurologi…
Sponsor: Pitié-Salpêtrière Hospital • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Gum width key to root coverage success, new study finds
Knowledge-focused Recruiting nowThis study looks at how the width of healthy gum tissue affects the success of covering exposed tooth roots in 30 adults with gum recession. Participants will receive a minimally invasive gum graft surgery. The goal is to see if wider gum tissue leads to better root coverage and …
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Is chronic elbow pain really a Whole-Body nerve problem?
Knowledge-focused Recruiting nowLateral epicondylitis, often called tennis elbow, causes pain and tenderness on the outside of the elbow and can linger despite treatment. Researchers are comparing 128 people with chronic lateral epicondylitis to healthy controls to see whether those with elbow pain have lower p…
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Digital sensor maps how jaw surgery moves the jaw joint
Knowledge-focused Recruiting nowResearchers at Semmelweis University are studying how orthognathic surgery, which realigns the upper and lower jaws, affects the temporomandibular joint and jaw movement. Fifty adults aged 18 to 45 with severe dentofacial deformities take part. Using a digital facebow device call…
Sponsor: Semmelweis University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New screening trial aims to speed up matching of cancer patients to the right treatments
Knowledge-focused Recruiting nowThis study tests a new way to screen patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) by analyzing their bone marrow and blood for specific biomarkers. The goal is to quickly match patients with a treatment trial that targets their cancer's unique mark…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study checks drug levels in breast milk for nursing moms
Knowledge-focused Recruiting nowThis study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not …
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists use manganese to peek inside 'Broken Hearts'
Knowledge-focused Recruiting nowThis study aims to better understand takotsubo cardiomyopathy, also known as broken heart syndrome, by using manganese-enhanced MRI scans. Researchers will test how different heart medications affect manganese uptake in the heart muscle. The study involves 100 adults who have had…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists scan brains to unravel why effort hurts in chronic fatigue
Knowledge-focused Recruiting nowThis study uses functional MRI to see how the brain processes unpleasant sensations like pain and physical effort in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy volunteers. Researchers will apply mild heat and ask participants to sq…
Early phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gum fluid proteins eyed as link between smoking and periodontitis
Knowledge-focused Recruiting nowResearchers are studying whether cigarette smoking is linked to levels of two proteins, MFN1 and NLRP3, in the fluid between the teeth and gums. The study includes 88 adults aged 25 to 65, split into four groups: nonsmokers and smokers with healthy gums, and nonsmokers and smoker…
Sponsor: Abant Izzet Baysal University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Major study tracks rare muscle disease to pave way for future treatments
Knowledge-focused Recruiting nowThis observational study aims to better understand primary mitochondrial myopathy, a rare muscle disease. Researchers will follow 1300 patients and healthy controls, measuring muscle strength, balance, and daily function over time. The goal is to develop and validate tools to tra…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Pregnancy hormone hCG may hold clues to bone and gland health
Knowledge-focused Recruiting nowResearchers are studying whether blood levels of luteinizing hormone (LH) and human chorionic gonadotropin (hCG) are linked to the presence, severity, and long-term outcomes of endocrine disorders such as osteoporosis, thyroid disease, and adrenal gland problems. The study enroll…
Sponsor: Martin Blomberg Jensen • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a COPD flare stun the heart? study watches for hidden strain
Knowledge-focused Recruiting nowResearchers at Sahlgrenska University Hospital in Sweden are observing 200 adults hospitalized for a severe COPD flare-up to see how often the condition triggers a temporary heart muscle weakness called Takotsubo stunning. They will use echocardiograms to check heart function at …
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Tooth pulp test may reveal which deep cavities heal without a root canal
Knowledge-focused Recruiting nowResearchers at a dental institute in India are studying whether levels of two inflammation markers, IL-1beta and IL-6, in the tooth's pulp can predict how well a full pulpotomy works. The procedure removes the inflamed crown portion of the pulp, caps it with a mineral-based mater…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Rare disease study seeks clues for future treatments
Knowledge-focused Recruiting nowThis study tracks the natural course of fucosidosis, a rare genetic disorder, in up to 57 people. It collects medical history and ongoing health data without giving any experimental treatment. The goal is to better understand the disease and help design future therapies.
Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Coin flip chemo: study tests if patients will let a computer choose their treatment strength
Knowledge-focused Recruiting nowThis study looks at whether adults with acute myeloid leukemia (AML) who are not healthy enough for strong chemotherapy are willing to let a computer randomly assign them to either lower- or higher-intensity treatment. The goal is to see if this approach is acceptable to patients…
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Global registry aims to map the full course of Charcot-Marie-Tooth disease
Knowledge-focused Recruiting nowResearchers are building a global registry to collect patient-reported surveys, genetic test results, and medical records from people with Charcot-Marie-Tooth disease and related inherited neuropathies. The study is open to children and adults with a confirmed or suspected diagno…
Sponsor: Hereditary Neuropathy Foundation • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Massive shoulder replacement study tracks 20,000 patients for over a decade
Knowledge-focused Recruiting nowThis study is tracking 20,000 people who have had or will have shoulder replacement surgery to see how well the implants work over at least 10 years. Researchers will measure pain, daily function, and strength using standard shoulder scores. The goal is to better understand the l…
Sponsor: Exactech • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves shed light on nerve and muscle health
Knowledge-focused Recruiting nowThis study uses ultrasound, a safe imaging technique that uses sound waves, to get detailed pictures and measurements of nerves and muscles. Researchers aim to collect normal values from healthy adults and compare them with data from people who have neuromuscular disorders. The g…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a deeper cleanup beat amyloidosis?
Knowledge-focused Recruiting nowThis study looks at 50 adults with AL amyloidosis who achieved complete remission after initial chemotherapy. It checks if tiny amounts of remaining disease (called minimal residual disease, or MRD) affect organ recovery and survival. Researchers also test whether a stem cell tra…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
AI could revolutionize thumb arthritis assessment
Knowledge-focused Recruiting nowThis study looks at thumb osteoarthritis, a common cause of pain and weakness at the base of the thumb. Researchers will assess 93 people using a broad approach that includes physical, psychological, and social factors. They will also test whether artificial intelligence can pred…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare family condition to uncover hidden clues about blood disorder
Knowledge-focused Recruiting nowThis study follows about 50 members of a family with a rare inherited condition called familial hypereosinophilia, where high levels of a type of white blood cell can damage the heart and nerves. Researchers will track participants over many years with yearly checkups, blood test…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive heart study seeks 5,000 volunteers to uncover hidden risks
Knowledge-focused Recruiting nowThis study aims to learn more about heart and blood vessel diseases by observing people who have them or are at risk. Researchers will collect samples and perform tests like imaging and stress tests on up to 5,000 participants, including healthy volunteers and relatives of affect…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to unlock secrets of rare inflammatory diseases
Knowledge-focused Recruiting nowThis study is for people with certain autoinflammatory diseases (like NOMID, DIRA, CANDLE, SAVI, and others) and their healthy relatives. Researchers want to learn more about what causes these diseases and how they affect the body over time. Participants will have medical tests a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into mouth bacteria to unlock immune secrets
Knowledge-focused Recruiting nowThis study looks at how genetic immune system problems might lead to gum disease and other mouth issues. Researchers will collect samples like saliva, plaque, and blood from 700 people, including those with immune defects, healthy adults with gum disease, and healthy adults witho…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists watch thyroid conditions unfold in 2,500 patients
Knowledge-focused Recruiting nowThis study follows up to 2,500 people with thyroid problems like hyperthyroidism, hypothyroidism, or Graves' disease. Researchers will track how these conditions develop over time using standard medical tests and genetic samples. The goal is to better understand the natural histo…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Kidney Patients' hidden risks: 1000-Person study aims to predict fractures and heart attacks
Knowledge-focused Recruiting nowThis study will follow 1000 adults with advanced chronic kidney disease (stage 4-5) to learn why they face higher risks of bone fractures and heart disease. Researchers will track bone turnover markers, calcium and phosphate levels, and kidney function over time. No new treatment…
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare bone disease under the microscope: what causes melorheostosis?
Knowledge-focused Recruiting nowThis study follows adults with melorheostosis, a rare disease that causes bone thickening, pain, and joint problems. Researchers will track how the disease progresses over time, collect genetic samples from patients and their relatives, and look for biomarkers. The goal is to bet…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can tracking MADD's natural course unlock better care?
Knowledge-focused Recruiting nowThis study follows people with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) over time to learn how the condition progresses and affects daily life. Researchers will collect health data and patient feedback to identify patterns and potential markers of the disease. The goal i…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New registry to monitor jaw joint replacements for better care
Knowledge-focused Recruiting nowThis study is a registry that will collect information from about 200 people who receive a total jaw joint (TMJ) replacement. Researchers will track their health, jaw function, and any complications for up to 5 years after surgery. The goal is to learn more about how these replac…
Sponsor: AO Innovation Translation Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can your genes predict eye damage from a common arthritis drug?
Knowledge-focused Recruiting nowThis study looks at whether certain genes make some people more likely to develop eye damage from the drug Plaquenil, which is used for autoimmune diseases like lupus and rheumatoid arthritis. Researchers will compare people who have had eye damage from Plaquenil with those who h…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Researchers launch major study to unravel mysteries of muscle disease
Knowledge-focused Recruiting nowThis study aims to learn more about myositis, a group of diseases that cause muscle inflammation and damage. Researchers will observe up to 1,200 children and adults with myositis, along with healthy volunteers, to track changes in the immune system and other health problems over…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists study mast cells to unlock mastocytosis mysteries
Knowledge-focused Recruiting nowThis study collects bone marrow and blood samples from up to 600 people with mastocytosis, a condition where too many mast cells cause symptoms like itching and bone pain. Researchers will study what makes these cells grow and survive. The goal is to learn more about the disease,…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study seeks answers for rare inherited nerve diseases
Knowledge-focused Recruiting nowThis study aims to learn more about rare inherited disorders that affect the brain, spinal cord, muscles, and nerves. Researchers will collect medical history, perform exams, and run genetic tests on up to 3,500 participants. No new treatments are tested; the goal is to better un…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to uncover genetic roots of Hormone-Driven high blood pressure in black communities
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of primary aldosteronism, a condition where adrenal tumors cause high blood pressure, in Black individuals. Researchers will enroll 1150 participants, including those with difficult-to-control blood pressure or known primary aldosteronis…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cured of cushing as a kid? scientists want to track your health for years
Knowledge-focused Recruiting nowThis study looks at the long-term health of people who were cured of Cushing disease before age 21. Researchers want to understand how past high cortisol levels affect the body and mind years later. Participants will complete surveys and have check-ups every 5 years. The goal is …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for gene behind rare kidney cancer syndrome
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of hereditary leiomyomatosis renal cell cancer (HLRCC), a condition that can lead to painful skin bumps, uterine fibroids, and kidney tumors. Researchers will study people with known or suspected HLRCC and their family members to iden…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for biomarkers to predict spinal stenosis progression
Knowledge-focused Recruiting nowThis study explores whether inflammation from fat tissue around the spine contributes to spinal stenosis, a condition that narrows the spinal canal and causes pain. Researchers will collect tissue and blood samples from 100 patients undergoing spinal surgery to measure levels of …
Sponsor: Poznan University of Physical Education • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tiny study could unlock secrets of genetic heart failure
Knowledge-focused Recruiting nowThis study follows 10 Chinese adults who have a specific gene mutation (BAG3) linked to dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Researchers will track changes in heart function, symptoms, and biomarkers over time to better understand how the…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to uncover cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare brain diseases to unlock clues for future treatments
Knowledge-focused Recruiting nowThis study follows people with rare genetic disorders that cause harmful substances to build up in the body, leading to brain damage. Researchers will monitor up to 200 participants over time using exams, surveys, and lab tests. The goal is to better understand how these diseases…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Your wisdom teeth could help science: study seeks tissue samples
Knowledge-focused Recruiting nowThis study collects wisdom teeth and surrounding tissue that are normally thrown away after oral surgery. Researchers will use these samples to learn more about oral health and disease. Up to 3,000 people aged 16 to 50 who need their wisdom teeth removed can join. The study also …
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch major study to unravel rare bone disease
Knowledge-focused Recruiting nowThis study follows up to 500 people with polyostotic fibrous dysplasia or McCune-Albright syndrome to learn how these conditions change over time. Researchers will collect medical data and tissue samples to better understand the disease. The goal is to improve future diagnosis an…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists seek clues on white blood cell behavior in allergies and parasites
Knowledge-focused Recruiting nowThis study aims to understand how and why eosinophils (a type of white blood cell) become active in conditions like allergies, asthma, and parasitic infections. Researchers will observe up to 800 people aged 1 to 100 with high eosinophil levels. No experimental treatments are giv…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Ventilator Patients' diaphragm decline measured in new study
Knowledge-focused Recruiting nowThis study tracks how quickly the diaphragm weakens in 15 ICU patients on mechanical ventilation. Researchers use advanced muscle tests and brain stimulation to measure changes in diaphragm function and control. The goal is to better understand ventilator-induced diaphragm dysfun…
Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
3,000 hearts, one goal: mapping how hypertrophic cardiomyopathy unfolds in china
Knowledge-focused Recruiting nowResearchers are following 3,000 Chinese adults with hypertrophic cardiomyopathy, a condition that thickens the heart muscle and can disrupt blood flow. The study records how patients are treated in everyday hospitals and tracks health events such as stroke, heart failure hospital…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Do genes drive heart damage from irregular rhythms?
Knowledge-focused Recruiting nowResearchers are studying people with arrhythmia-induced cardiomyopathy, a condition where a fast or irregular heartbeat weakens the heart muscle. The study checks whether these patients carry more harmful gene variants than people with other types of cardiomyopathy or the general…
Sponsor: Hospital Universitario 12 de Octubre • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New MRI techniques aim to sharpen heart disease detection
Knowledge-focused Recruiting nowThis study aims to develop and test new MRI methods for imaging the heart and blood vessels to improve diagnosis and management of heart disease. It will enroll up to 3,400 adults, including both patients with heart conditions and healthy volunteers. Participants will undergo MRI…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Walking study aims to unlock secrets of stiff muscles after stroke
Knowledge-focused Recruiting nowThis study looks at how the Achilles tendon behaves during walking in people with spastic paresis, a condition causing muscle stiffness after stroke or spinal cord injury. Researchers will measure tendon stiffness, length, and volume using ultrasound and motion analysis. The goal…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can we map the course of a rare mitochondrial disease?
Knowledge-focused Recruiting nowThis global study follows people with POLG-related disorders, a group of rare mitochondrial conditions, to understand how the disease progresses over time. By observing clinical changes in up to 300 participants of all ages, researchers aim to identify key milestones that could s…
Sponsor: The POLG Foundation • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Joint tissue study aims to personalize rare disease treatment
Knowledge-focused Recruiting nowThis study looks at whether analyzing synovial tissue can help doctors better manage pigmented villonodular synovitis (PVNS), a rare joint disease that causes pain and joint damage. Researchers will collect tissue samples from 30 patients through biopsy or surgery to assess quali…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New study tracks safety of eplontersen in patients with liver transplants
Knowledge-focused Recruiting nowThis observational study monitors the long-term safety of eplontersen, a treatment for transthyretin amyloidosis, in patients who have had a liver transplant or have severe liver impairment. Researchers will track side effects, lab changes, and serious health events in about 320 …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
20-Year study to track rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows people with acquired or inherited bone marrow failure for up to 20 years to learn how the diseases and treatments affect the body over time. Participants, aged 2 and older, will have regular check-ups and tests every 1 to 3 years. The goal is to better understa…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Short bursts of low oxygen may boost breathing after spinal injury
Knowledge-focused Recruiting nowThis study tests whether short episodes of breathing low-oxygen air can improve breathing strength in people with chronic spinal cord injury. Participants will try three different breathing sessions (low oxygen, low oxygen with extra carbon dioxide, and normal air) to see which w…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Scientists track spondyloarthritis in families to uncover clues to severe disease
Knowledge-focused Recruiting nowThis study follows up to 2,000 people with spondyloarthritis (a group of inflammatory joint and spine conditions) and their healthy relatives. Researchers aim to identify symptoms, genetic factors, and medical tests that predict who will develop more severe forms of the disease. …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Real-World data may unlock Pacritinib's true potential in myelofibrosis
Knowledge-focused Recruiting nowThis study looks back at medical records of adults with myelofibrosis who took pacritinib for at least a month. Researchers will track changes in spleen size, blood counts, symptoms, and survival to see how the drug performs in everyday practice. The goal is to understand real-wo…
Sponsor: Swedish Orphan Biovitrum • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Heart rhythm gene hunt: 2,000 patients join biobank
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2,000 people with or without heart rhythm problems. Researchers will analyze the samples to find genetic differences linked to arrhythmias. The goal is to better understand the causes of these conditions, not to test a new treatme…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
NIH launches data repository to fuel future research on rare nerve and muscle diseases
Knowledge-focused Recruiting nowThis study gathers medical information from 200 adults with possible nerve, muscle, or autonomic nervous system disorders who are not already in other NIH studies. Participants undergo standard tests like nerve conduction studies, EMG, and physical exams. The data is stored anony…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can a smartwatch track how kids recover from cancer surgery?
Knowledge-focused Recruiting nowThis study is testing whether smartwatches and blood tests can measure how well children recover after surgery to remove a solid tumor. About 40 children and their caregivers will wear smartwatches and answer questionnaires before surgery and for up to a year after. Researchers w…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Heart rhythm mystery: study seeks clues to AF in Thick-Hearted patients
Knowledge-focused Recruiting nowThis study will look at 40 people with both hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) to understand why AF is more common and harder to treat in HCM. Researchers will measure electrical signals in the heart and use advanced imaging. The goal is to find clues …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can some children with a pointed skull skip major surgery?
Knowledge-focused Recruiting nowTrigonocephaly is a condition where a baby's skull fuses too early along the forehead, giving the head a pointed shape. Doctors often operate to relieve pressure on the growing brain, but some children may do just as well without surgery. This study follows children aged 0 to 8 w…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Telehealth program aims to improve end-of-life conversations for older cancer patients
Knowledge-focused Recruiting nowThis study tests a telehealth program that helps older adults (60+) with blood cancers like leukemia or MDS talk to their doctors about their care wishes. The program also helps them fill out advance directive forms. Researchers want to see if it improves communication and reduce…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Hidden cost of cancer: study probes financial toxicity in sarcoma patients
Knowledge-focused Recruiting nowThis study looks at the financial stress that patients with bone or soft tissue sarcoma face after surgery. Researchers will ask 100 adults to fill out questionnaires about the costs of their cancer care and how that affects their quality of life. No new treatments are being test…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Scientists track rare gene variant to unlock blood disorder mysteries
Knowledge-focused Recruiting nowThis study follows people of all ages who have or may have a RUNX1 gene variant, which can cause bleeding problems and increase the risk of blood cancers. Researchers will collect medical history, blood samples, and bone marrow over many years to understand how the condition deve…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Disposable scope takes on gold standard in pleural diagnosis
Knowledge-focused Recruiting nowThis pilot trial tests whether a single-use flexible bronchoscope can safely and effectively replace the semi-rigid pleuroscope for diagnosing pleural effusion—a buildup of fluid around the lungs. Hospitalized patients needing a tissue sample will be randomly assigned to one of t…
Sponsor: National University of Malaysia • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Pacemaker study aims to predict and prevent heart weakening
Knowledge-focused Recruiting nowThis study is observing 4,500 people who need pacemakers or similar heart devices. The goal is to create a tool that predicts who is at risk of developing a weakened heart from the device itself. By identifying high-risk patients early, doctors can choose better pacing methods to…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Blood cancer registry tracks thousands to map disease course
Knowledge-focused Recruiting nowResearchers are building a registry to collect long-term health information from adults with myelodysplastic syndromes and therapy-related acute myeloid leukemia. The study gathers details on blood counts, bone marrow tests, genetic changes, and treatments. By following these pat…
Sponsor: Groupe Francophone des Myelodysplasies • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
New study tracks rare muscle disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows 150 people aged 7 and older with RYR1-related muscle disorders for 3 to 5 years. Researchers will collect medical history, perform physical exams, and use questionnaires, activity trackers, and tests of heart, lung, and muscle function. The goal is to better un…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Gum Surgery's hidden impact: blood tests reveal stress response
Knowledge-focused Recruiting nowThis study looks at how gum surgery changes inflammation markers in the blood. Researchers will take blood samples from 30 adults before, during, and after dental procedures. The goal is to see if surgical stress causes a different inflammatory response compared to non-surgical c…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Cancer immunotherapy can attack the heart: massive data hunt seeks who is most vulnerable
Knowledge-focused Recruiting nowImmune checkpoint inhibitors help the body's immune system fight cancer, but in some patients they trigger dangerous heart inflammation and other cardiovascular problems. Researchers are combing through the World Health Organization's global drug safety database, two French natio…
Sponsor: Groupe Hospitalier Pitie-Salpetriere • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can paired brain and nerve stimulation strengthen movement pathways after spinal cord injury?
Knowledge-focused Recruiting nowResearchers are studying how aging and spinal cord injury affect two nerve pathways that help control leg movement: the corticospinal and reticulospinal tracts. The trial enrolls adults with chronic spinal cord injury and healthy controls. Participants receive transcranial magnet…
Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Why do some joint replacements get infected? moscow study hunts for clues
Knowledge-focused Recruiting nowResearchers in Moscow are studying patients who have knee or hip replacement surgery to learn why some develop serious infections around the implant. The study will follow 750 adults aged 45 and older, checking their immune status, mineral metabolism, and tissue samples before an…
Sponsor: People's Friendship University of Russia • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study aims to predict which heart patients will respond to therapy
Knowledge-focused Recruiting nowThis study will observe 253 adults with heart rhythm problems who are scheduled for procedures like pacemakers or ablation. Researchers will use advanced imaging and AI tools to understand why some patients respond well to treatment while others do not. The goal is to find better…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Vibration and baduanjin put muscle activation under the microscope
Knowledge-focused Recruiting nowResearchers are studying how short bursts of whole-body vibration, vibration combined with plantar stimulation, and a Baduanjin heel-raise exercise affect lower-limb muscle activity in young adults with flat feet and normal feet. Thirty college students will complete all conditio…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Which root canal device kills more bacteria? new study aims to find out
Knowledge-focused Recruiting nowThis study tests three different devices used during root canal treatment to see which one removes the most bacteria from infected teeth. Ninety adults with dead nerves in their premolars will be randomly assigned to one of the three methods. Researchers will measure bacterial le…
Sponsor: Abhishek Parolia • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists investigate rare overgrowth disorder proteus syndrome
Knowledge-focused Recruiting nowThis study aims to understand the genetic and biological causes of Proteus syndrome, a rare condition causing abnormal growth of bones, skin, and other tissues. Researchers will follow up to 1,500 participants over time, using medical exams, imaging, and blood tests to track how …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can a less invasive disc surgery mean less pain right after?
Knowledge-focused Recruiting nowThis study looks at whether a newer, minimally invasive endoscopic technique for removing a herniated disc leads to less back pain in the first few days after surgery compared with traditional open surgery. Researchers will follow 140 adults scheduled for lumbar discectomy and me…
Sponsor: Saint-Gregoire Private Hospital Center • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Researchers launch study to unravel mysteries of rare immune disorder sHLH
Knowledge-focused Recruiting nowThis study aims to understand why some adults develop secondary hemophagocytic lymphohistiocytosis (sHLH), a serious immune condition causing fevers and organ damage. Researchers will follow 300 participants for up to 3 years, collecting blood samples and medical data to identify…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can weak muscles slow down hip surgery recovery? new study aims to find out
Knowledge-focused Recruiting nowThis study at Montpellier University Hospital will look at whether low muscle mass and strength before hip replacement surgery affects how well people aged 75 and older regain their independence. About 20 volunteers will have blood tests, scans, and a tiny muscle sample taken dur…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study tracks sinus health in kids with cystic fibrosis on breakthrough drugs
Knowledge-focused Recruiting nowThis study follows 80 children aged 2-8 with cystic fibrosis to see how highly effective CF drugs (Kalydeco or Trikafta) impact sinus disease and sense of smell. Researchers will use MRI scans, smell tests, and quality-of-life surveys over two years. The goal is to understand whe…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can sinus surgery help cystic fibrosis lungs? new study investigates
Knowledge-focused Recruiting nowThis study follows 170 adults with cystic fibrosis and chronic sinusitis to see if sinus surgery improves lung function and quality of life compared to medical treatment alone. Participants either have surgery or continue with standard care. Researchers will track changes in brea…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study tests if education can reduce heart risks after spinal cord injury
Knowledge-focused Recruiting nowThis study aims to see if a specially designed education module helps people with spinal cord injury (SCI) learn about their increased risk for heart disease, obesity, and metabolic problems. Researchers will enroll 250 adults with SCI and measure changes in knowledge, body weigh…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Estrogen drop may hold clue to bladder leaks in women with spinal cord injury
Knowledge-focused Recruiting nowWomen with spinal cord injury often deal with urinary incontinence, but most research has focused on women after menopause. This pilot study asks whether the natural drop in estrogen after ovulation could make incontinence more frequent. Twenty-four women will track their menstru…
Sponsor: Swiss Paraplegic Research, Nottwil • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can a smartphone replace a dental scanner for implant impressions?
Knowledge-focused Recruiting nowThis trial tests whether a smartphone-based photogrammetry system (T-Marker) can match or beat a specialized intraoral scanner with splinting bodies (IoConnect) for recording implant positions in people with full-arch dental implants. Each participant will be scanned with both me…
Sponsor: Menoufia University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Broken heart syndrome: is it as deadly as a heart attack?
Knowledge-focused Recruiting nowTakotsubo cardiomyopathy, often called broken heart syndrome, mimics a heart attack and is triggered by intense emotional or physical stress. Researchers at the University of Aberdeen are identifying every diagnosed case in Scotland since 2010 to measure death rates and hospitali…
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood protein clues may predict chemo success in older cancer patients
Knowledge-focused Recruiting nowThis study looks at 60 adults with acute myeloid leukemia or related blood cancers who are receiving a gentler type of chemotherapy. Researchers will measure certain proteins in the blood to see if they can predict how well the treatment works. The goal is to better understand wh…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Global study tracks Real-World impact of new heart drug
Knowledge-focused Recruiting nowThis study will follow about 2000 adults with a heart condition called ATTR-CM, where abnormal proteins build up and weaken the heart. Researchers want to see how patients do on a drug called vutrisiran in everyday medical care, not just in a controlled trial. They will measure s…
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists probe a muscle protein that may hold clues to Age-Related weakness
Knowledge-focused Recruiting nowResearchers at the University of Oregon are studying how a protein in skeletal muscle called myosin binding protein C, or MyBP-C, changes with fatigue and aging. The study compares healthy adults aged 18 to 35 with adults aged 65 to 80. Participants perform knee extension exercis…
Sponsor: University of Oregon • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Massive ATTR amyloidosis study aims to map disease journeys
Knowledge-focused Recruiting nowThis observational study will analyze medical records from over 52,000 people with ATTR amyloidosis, a rare disease where abnormal proteins build up in organs. Researchers want to learn about patients' symptoms, treatments, and outcomes in everyday medical practice. No new treatm…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New MRI study aims to sharpen heart imaging and check for gadolinium traces
Knowledge-focused Recruiting nowThis study aims to develop better MRI methods for imaging the heart and brain, and to describe heart diseases using these new techniques. It will also investigate whether gadolinium, a common MRI contrast agent, stays in the body long after use. Up to 5,000 healthy volunteers and…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New laser device could revolutionize eye disease detection
Knowledge-focused Recruiting nowThis study is testing a new non-invasive device that uses laser speckle to measure blood flow and structure inside the eye. Researchers will compare these images with standard vision tests in 500 people with various retinal conditions. The goal is to see if this technology can be…
Sponsor: Randy Kardon • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One million volunteers join quest to decode aging
Knowledge-focused Recruiting nowThis observational study will enroll up to one million adults to understand how health, environment, and lifestyle affect aging and disease. Researchers will link participants' clinical data with information from public records, such as pollution and social factors, to create a d…
Sponsor: Longevity Metrics, Inc. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One million volunteers join quest to decode aging
Knowledge-focused Recruiting nowThis study will follow 1,000,000 adults aged 18 and older for the rest of their lives. Researchers will collect health measurements and track who develops diseases, becomes frail, or dies. The goal is to find which tests best predict how well people age, so doctors can one day of…
Sponsor: Longevity Metrics, Inc. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can online classes beat Face-to-Face lessons for bone health?
Knowledge-focused Recruiting nowThis study tests whether digital education or in-person classes help people over 50 with osteoporosis take better care of themselves. Six hundred participants will be split into three groups: one gets standard information, another attends three group sessions with a physiotherapi…
Sponsor: University Hospital, Linkoeping • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists hunt for genetic clues behind childhood pituitary tumors
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of pituitary and hypothalamic tumors in children. Researchers will collect blood and tumor samples from up to 2,000 participants to analyze DNA and look for inherited patterns. The study also trains doctors and tests new MRI technique…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Placebo surgery to reveal truth about back pain operations
Knowledge-focused Recruiting nowThis study aims to find out if spinal fusion surgery truly helps people with long-term low back pain. Ninety adults with severe, persistent pain will undergo surgery, but half will receive a placebo procedure without fusion. Neither the patients nor their care team will know whic…
Sponsor: Uppsala University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Blood test may spot worn spinal discs behind chronic back pain
Knowledge-focused Recruiting nowThis study looks at whether a protein called BDNF in the blood matches the degree of spinal disc wear seen on MRI and levels of an inflammation marker called IL-1β. Researchers will measure BDNF in blood samples from 59 people with low back or leg pain caused by disc degeneration…
Sponsor: Keimyung University Dongsan Medical Center • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
NCI opens screening study for experimental cell therapies in multiple cancers
Knowledge-focused Recruiting nowThis study screens adults with certain cancers (like melanoma, lung, or colorectal cancer) to see if they qualify for experimental treatments being tested by the NCI Surgery Branch. These treatments involve taking a patient's own immune cells, growing them in a lab, and giving th…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple ultrasound predict outcomes in sick Moms-to-Be?
Knowledge-focused Recruiting nowThis study uses ultrasound to measure muscle, fat, and fluid changes in 121 critically ill pregnant or gynecological patients in the ICU. The goal is to see if these body composition changes are linked to serious outcomes like death, need for a breathing machine, or longer hospit…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Veterans with spinal injury may have hidden nerve pathways, new study hopes to find
Knowledge-focused Recruiting nowThis study looks at 40 veterans with chronic spinal cord injury to find any remaining nerve connections below their injury. Researchers will use MRI scans and non-invasive stimulation to measure these connections. The goal is to understand who might benefit from future treatments…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New study to see which back procedure keeps seniors out of surgery
Knowledge-focused Recruiting nowThis study will follow 8,000 Medicare patients with lumbar spinal stenosis who receive either the MILD procedure or interspinous process decompression. Researchers will track complications and whether patients need additional surgery within two years. The goal is to see which app…
Sponsor: Stryker Instruments • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
A nationwide effort to map a rare blood Cancer's toll
Knowledge-focused Recruiting nowResearchers in Italy are building a large registry of adults newly diagnosed with myelodysplastic syndromes, a group of blood cancers where the bone marrow does not make enough healthy blood cells. The study will collect data on up to 10,000 people to measure how many new cases o…
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Scientists hunt for biomarkers to unlock DM1 treatments
Knowledge-focused Recruiting nowThis study follows 1,000 adults with myotonic dystrophy type 1 (DM1) over time to measure how the disease progresses. Researchers will track walking speed, hand muscle relaxation, grip strength, heart and lung function, and daily activity. The goal is to establish reliable biomar…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC